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Résumé 
La transcription des gènes codant pour des protéines est réalisée par l’ARN polymérase II (Pol 
II). Cette enzyme est composée de 12 sous-unités nommées Rpb1 à Rpb12 et possède sur sa 
plus grande sous-unité, Rpb1, un domaine carboxy-terminal (CTD) constitué de répétitions de 
l’heptapeptide Y1-S2-P3-T4-S5-P6-S7. Chacun de ces résidus peut être modifié afin de créer 
différentes combinaisons de séquences permettant le recrutement de facteurs impliqués dans la 
maturation des ARNm. Les modifications les plus abondantes sont la phosphorylation de la 
sérine en position 2 (CTD-Ser2) et 5 (CTD-Ser5) par les kinases dépendantes des cyclines, 
CDK7 (qui phosphoryle la CTD-Ser5) et CDK12/CDK9 (qui phosphorylent la CTD-Ser2). 
Bien que CDK9 soit essentielle pour l’embryogenèse, CDK12 ne l’est pas et semble être 
importante uniquement pour la transcription d’un groupe de gènes impliqués dans le 
développement post-embryonnaire chez l’organisme modèle Caenorhabditis elegans. En effet, 
dans le laboratoire, de précédentes études ont démontré que l’inhibition de CDK-12 chez C. 
elegans entraîne un arrêt développemental au stade post-embryonnaire L1.  
Le but de ce mémoire est de poursuivre l’étude de CDK-12, premièrement en vérifiant que le 
phénotype induit par son inactivation résulte bien d’un déficit de phosphorylation des sérines 
en position 2 du CTD et deuxièmement en étudiant la régulation de CDK-12 in vivo. Nous 
avions donc pour but de générer deux souches transgéniques, exprimant soit un CTD où les 
sérines en position 2 sont remplacées par un résidu non-phosphorylable, soit CDK-12 taggée 
afin d’étudier sa phosphorylation et ses interactants éventuels par spectrométrie de masse. Dans 
les deux cas, plusieurs variations de la méthode CRISPR/Cas9 ont été utilisées sans succès. Une 
souche transgénique contrôle ciblant un autre gène a été obtenue, indiquant que la méthode est 
efficace. 
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Summary 
The transcription of protein-coding genes is realized by the RNA polymerase II (Pol II). This 
enzyme is composed of 12 subunits named Rpb1 to Rpb12 and possesses on its largest subunit, 
Rpb1, a tail-like carboxy-terminal domain (CTD) composed of repetitions of the heptapeptide 
sequence Y1-S2-P3-T4-S5-P6-S7. Each of the CTD residues can be post-translationally modified 
to form different combinations allowing factors involved in mRNA processing and maturation 
to dock on Pol II. The most abundant modifications are the phosphorylation of the serine in 
position 2 (CTD-Ser2) and 5 (CTD-Ser5) by the Cyclin-Dependent Kinases, CDK7 (which 
phosphorylates the CTD-Ser5) and CDK9/CDK12 (which phosphorylate the CTD-Ser2). 
Although CDK9 is essential for embryogenesis, CDK12 is not and is rather required for the 
expression of a subset of genes like genes involved in postembryonic development in the model 
organism Caenorhabditis elegans. Indeed, previous work from the lab showed, that the 
inactivation of CDK-12 in C. elegans results in an early post-embryonic developmental arrest 
at the L1 stage.  
The goal of this master thesis is to pursue the study of CDK-12 by checking that the phenotype 
induced by its inactivation is indeed consequent to a deficit of CTD-Ser2 phosphorylation and 
second, by studying how CDK-12 is regulated in vivo. We thus aimed to create two C. elegans 
mutant strains, one expressing a CTD where the CTD-Ser2 are replaced by a non-
phosphorylable residue and another expressing a tagged CDK-12 to study its phosphorylation 
status and putative partners by mass spectrometry. To generate these two strains, we used 
several variations of the CRISPR/Cas9 method, so far with no success. A transgenic control 
strain targeting another gene was obtained, which indicates that the method is efficient. 
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Introduction  
1. Transcription 
1.1. The central dogma of molecular biology 
In 1958, Francis Crick argued that the hereditary information contained in DNA is first 
transformed into RNA and then into proteins. That is what we call nowadays “the central dogma 
of molecular biology” (Shapiro, 2009). The first step, the transcription of DNA into RNA, is 
performed into the nucleus by enzymes named RNA polymerases. The RNA is then exported 
into the cytoplasm where it can play its role or be translated into proteins by ribosomes (Clancy 
and Brown, 2008).  
 
1.2. The different RNA polymerases 
As mentioned, transcription is performed by RNA polymerases. While eubacteria and 
archaea possess only a single RNA polymerase, eukaryotes have at least three, the RNA 
polymerase I (Pol I), the RNA polymerase II (Pol II) and the RNA polymerase III (Pol III) 
(Cramer et al, 2008). Pol I is a complex of 14 subunits responsible for the transcription of large 
ribosomal RNA precursors. These RNAs will be processed into the 28S, 18S and 5.8S 
ribosomal RNAs (Cramer et al, 2008; Cooper, 2000). Pol II is a complex of 12 subunits (Rpb1 
to Rbp12) that transcribes coding sequences into pre-mRNAs. It is also responsible for the 
transcription of most non-coding RNAs (ncRNAs). These ncRNAs have a lot of functions such 
as the regulation of the gene expression during healthy or pathological development, the 
translation regulation or even the pre-mRNA processing (Cramer et al, 2008; Cooper, 2000, 
Mattick and Makunin, 2006). Pol III is composed of 17 subunits. This RNA polymerase 
transcribes the transfer RNAs and short ncRNAs (Cramer et al, 2008; Cooper, 2000). Two other 
RNA polymerases, the RNA polymerase IV (Pol IV) and the RNA polymerase V (Pol V) can 
be found in plants. Pol IV seems to be implicated in the transcription of small interfering RNAs 
and Pol V in gene silencing (Zhou and Law, 2015).  
 
1.3. The RNA polymerase II CTD 
Pol II differs from Pol I or Pol III by the presence of a carboxy-terminal domain (CTD) on 
its largest subunit, Rpb1 also called AMA-1 in Caenorhabditis elegans (Bowman and Kelly, 
2014). The CTD is composed of repetitions of the heptapeptide sequence Y1-S2-P3-T4-S5-P6-S7 
and the number of repetitions depends on the complexity of the organism, with 26 repetitions 
for the yeast Saccharomyces cerevisiae, 42 for C. elegans and 52 for mammals (Corden, 1990). 
The CTD is not required for the catalytic activity of the polymerase as an in vitro study showed 
that Pol II has similar transcriptional activity with or without the CTD (Kim and Dahmus, 
1989). However, in vivo, the deletion of the CTD is lethal in yeast, Drosophila melanogaster, 
and mammalian cells even if it can be truncated (Corden, 2013). Indeed, in yeast, the CTD can 
be cut to leave only 10 repeats without affecting the viability (Nonet et al, 1987) and 
mammalian cells expressing a CTD with 35 repetitions can be maintained in culture despite 
showing lower cell viability (Chapman et al, 2005). All those studies thus suggested that the 
CTD is not required for the catalytic activity of the polymerase but is still important for several 
cellular functions. That could be explained by the fact that the CTD does not play a role in the 
Table 1: CDKs orthologs in various species. The principal CDKs phosphorylating the CTD serines with their
orthologs in several species and their CTD target(s) (Malumbres, 2014).
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transcription process itself but rather in the processing of the pre-mRNA by recruiting proteins 
close to the RNA polymerase II. Indeed, each of the CTD tyrosine, threonine, and serine 
residues can be phosphorylated or glycosylated and the proline residues can be isomerized. In 
addition, it exists non-consensus repeats containing lysines and arginines which can be 
modified by acetylation, methylation or ubiquitination (Ranuncolo et al, 2012; Zaborowska et 
al, 2016). Thanks to all these post-translational modifications, the CTD is thought to act as a 
platform for proteins docking on Pol II allowing the coupling of mRNA transcription, 
maturation, and processing (Zaborowska et al, 2016).  
The most studied modifications are the phosphorylations, particularly the phosphorylation 
of the serine in position 2 (CTD-Ser2) and in position 5 (CTD-Ser5) because they are the most 
abundant. Indeed, immunopurification and mass-spectrometry analyses of CTD peptides 
showed that the phosphorylated CTD-Ser2 (CTD-Ser2P) and CTD-Ser5 (CTD-Ser5P) 
represent 75% of the total phosphorylated amino acids while the phosphorylated threonine 4 
represents only 15% and the phosphorylated tyrosine 1 and serine 7 represent less than 5% 
(Schüller et al, 2016).  
 
1.4. The CTD kinases  
The kinases phosphorylating the CTD serines belong to the Cyclin-Dependent Kinase 
(CDK) family. CDKs are serine/threonine kinases whose activity requires the binding of a 
regulatory subunit, a cyclin. The CDKs can be divided into two groups, CKDs that can bind 
multiple cyclins and are involved in the regulation of the cell cycle and CDKs that can bind 
only one cyclin and are involved in the regulation of transcription (Malumbres, 2014). There 
are four principal CDKs phosphorylating the CTD serines and involved in the transcription 
cycle (Table 1). CDK7 is part of the TFIIH transcription factor and is responsible with its cyclin 
H for the phosphorylation of the CTD-Ser5 and CTD-Ser7 during the initiation of the 
transcription cycle (Malumbres, 2014). CDK8 is part of the Mediator complex and seems to 
phosphorylate the CTD-Ser2 and CTD-Ser5 in vitro. In vivo, CDK8 seems to phosphorylate the 
CTD-Ser5 and to positively regulate the transcription even if its function is highly debated 
(Zaborowska et al, 2016; Tsutsui et al, 2011). CDK9 associates with its cyclin T and forms the 
elongation factor P-TEFb. CDK9 phosphorylates the CTD-Ser2 and CTD-Ser5 allowing 
complex involved in capping and splicing to dock on Pol II (Malumbres, 2014). CDK12 is the 
last kinase involved in the phosphorylation of the CTD. It is implicated with its cyclin K in the 
phosphorylation of the bulk of CTD-Ser2 in order to recruit complexes necessary for the 
cleavage and polyadenylation of the pre-mRNA (Malumbres, 2014). This last kinase is 
particularly interesting because, for a long time, the scientific community thought that CDK9 
was the genuine and only CTD-Ser2 kinase (Bartkowiak and Greenleaf, 2011). However, in 
2010, Bartkowiak and co-workers proved that CDK12 is a bona fide CTD-Ser2 kinase. Indeed, 
they showed by Western blot that treating cells with dsRNAs targeting exons of CDK12 
dramatically reduces the phosphorylation of CTD-Ser2 but has no impact on the 
phosphorylation of CTD-Ser5 (Bartkowiak et al, 2010).  
The other residues of the CTD can also be phosphorylated. Indeed, CDK9 can also 
phosphorylate the CTD-Thr4 (Hsin et al, 2011) and the CTD-Tyr1 can be phosphorylated by 
the c-Abl kinase (Baskaran et al, 1993) but the biological relevance of these marks remains 
largely untested. 
Figure 1: Pol II transcription cycle with the CTD code. The non-phosphorylated CTD Pol II with general transcription
factors (GTFs) and the Mediator complex form the Pre-Initiation Complex (PIC). Conformational changes of the PIC allow
the initiation step to begin, but at this stage, the polymerase is still linked to the promoter. The phosphorylation of the CTD-
Ser5 and CTD-Ser7 by the subunit CDK7 of the transcription factor TFIIH release Pol II, leading to the elongation step.
However, this early elongation is stopped by Pol II pausing, removed by the phosphorylation of DSIF and NELF by the
subunit CDK9 of P-TEFb. CDK9 also phosphorylates the CTD-Ser5 allowing the addition of the cap (m7G). During the
elongation step, CDK9 phosphorylates the CTD-Ser2 and RPAP2 begins to dephosphorylate the CTD-Ser5. This allows to
recruit the spliceosome (SP). The last step of the transcription cycle is the termination where Ssu72 dephosphorylates the
CTD-Ser7 and CTD-Ser5 and where CDK12 phosphorylates the CTD-Ser2. This allows to recruit the cleavage and
polyadenylation machinery (CPSF and CstF). When the cycle is finished, Fcp1 dephosphorylate the CTD-Ser2 and the
polymerase can begin a new cycle (adapted from Zhang et al, 2012a).
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1.5. The CTD phosphatases  
The phosphorylation of the CTD serines is very dynamic with phosphorylation and 
dephosphorylation during the transcription cycle. Indeed, the CTD-Ser7 is phosphorylated by 
CDK7 at the beginning of the transcription cycle and is dephosphorylated by a phosphatase 
called Ssu72 in the 3’ region of the transcript unit. It is a necessary event for transcription 
termination (Zhang et al, 2012b). The CTD-Ser5P is important to recruit the capping 
machinery. It is dephosphorylated by RPAP2 in the 5’ region and by Ssu72 in the 3’ region 
(Egloff et al, 2012; Krishnamurthy et al, 2004). The phosphate on the CTD-Ser2 is removed by 
Fcp1 near the termination site (Cho et al, 2001).  
 
1.6. The RNA polymerase II transcription cycle 
The transcription is a six-step cycle comprising the Pre-Initiation Complex (PIC) assembly, 
the open complex formation, the initiation, the promoter clearance, the elongation, and the 
termination (Figures 1 and 2) (Svejstrup, 2004).  
The PIC is composed of the general transcription factors (TFIIB, TFIID, TFIIE, TFIIH, and 
TFIIF), the Mediator complex and the non-phosphorylated CTD Pol II. This complex assembles 
at the promoter region. The promoter region is composed of several elements such as the TATA, 
the CAAT or the GC box (Karp, 2010). The first step is the binding of TFIID to the TATA box 
(25bp upstream the transcription start site) thanks to its TATA Binding Protein (TBP). TFIIB 
next interacts with TBP and recruits TFIIF accompanied by Pol II. TFIIH and TFIIE next join 
the complex. TFIIE regulates TFIIH that possesses a helicase activity to open the DNA, an 
ATPase activity and a kinase activity mediated by CDK7 (Orphanides et al, 1996). The 
Mediator complex is also part of the Pre-Initiation Complex. It serves as a link between the PIC 
and non-general transcription factors to “transmit” information from these factors to the 
polymerase (Björklund and Gustafsson, 2005). The next step is the open complex formation 
performed by the action of TFIIH which opens the DNA. This leads to conformational changes 
of the PIC to form an open complex ready to transcribe (Cheung and Cramer, 2012; Kumar et 
al, 1998). The initiation step can thus start and the polymerase synthesizes the first nucleotides. 
However, at this stage, Pol II is still linked to the Pre-Initiation Complex and to release it, CDK7 
phosphorylates the CTD-Ser5 and CTD-Ser7. It dissociates the Mediator from the PIC and 
releases the polymerase leading to the elongation step of the transcription (Wong et al, 2014). 
Nevertheless, this early elongation is stopped by Pol II pausing due to both the intrinsic capacity 
of the polymerase for pausing and to the action of the regulatory factors DSIF (DRB-
Sensitivity-Inducing-Factor) and NELF (Negative Transcription Elongation Factor) (this last 
complex is absent in some species of nematodes, S. cerevisiae, and plants) (Yamaguchi et al, 
2013). This pausing allows the regulation of the transcription. Indeed, it is a rate-limiting step 
that can impact the mRNA abundance because the polymerase can even continue the 
transcription cycle or “fail” from the gene to stop the transcription. It has also other functions 
as helping the addition of the cap to the pre-mRNA or the coupling of the translation with the 
transcription in bacteria (Mayer et al, 2017). Pol II pausing is relieved by the phosphorylation 
of DSIF and NELF by the CDK9 kinase as part of the factor P-TEFb. Those phosphorylations 
dissociate NELF from the DNA and change the conformation of DSIF which becomes a 
positive elongation factor (Bowman and Kelly, 2014; Yamaguchi et al, 2013). CDK9 is also 
responsible, at least partly, for the phosphorylation of the CTD-Ser5 allowing the recruitment 
of the capping enzymes (Zaborowska et al, 2016). Indeed, a mutant yeast expressing alanine 
Figure 4: Principle of the torpedo model. The cleavage
of the pre-mRNA generates a uncapped 5’ PO4 extremity
(5’P) which can serve as a substrate for the enzyme
XRN2. XRN2 thus degrades the left-over RNA, reaches
Pol II and dissociate the elongation complex (adapted
from Kornblihtt, 2004).
Figure 3: Principle of the allosteric
model. As the cleavage and
polyadenylation factor Pcf11 is linked to
the CTD-Ser2P and to the nascent
transcript, when the CTD changes its
conformation at the poly(A)-signal, Pcf11
follows it, generating some pressure on
the nascent RNA. This disrupts the
complex formed between the nascent
RNA and the template DNA leading to
the disassembly of the elongation
complex (Zhang et al, 2005).
Figure 2: CTD-Ser2 and CTD-Ser5 phosphorylation during the transcription cycle. The CTD-Ser5P is present during
the initiation and elongation step and plays a role to recruit the capping machinery and the spliceosome. The CTD-Ser2P is
present during the elongation and termination step and plays a role in the recruitment of the spliceosome and the cleavage and
polyadenylation factors.
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instead of serine 5 (CTD-S5A) is lethal, but by fusing the capping enzyme MceI to Pol II 
expressing a CTD-S5A, the viability is restored suggesting that the only essential function of 
the CTD-Ser5P is to recruit the capping machinery, at least in yeast (Schwer and Shuman, 
2011). After the action of P-TEFb, Pol II is able to transcribe the gene, it is the elongation step. 
During this step, CDK9 will phosphorylate the CTD-Ser2 and RPAP2 will remove the 
phosphate on the CTD-Ser5. It means that during this step, the rate of CTD-Ser2P increases 
while the CTD-Ser5P decreases. This presence at the same time of CTD-Ser5P and CTD-Ser2P 
enables the spliceosome and CDK12 to join the pre-mRNA and Pol II (Bowman and Kelly, 
2014; David et al, 2011). At the 3’ end of the gene, Pol II enters in the last step of the 
transcription cycle, the termination. During this step, Ssu72 is working and dephosphorylate 
the CTD-Ser7 and CTD-Ser5 while CDK12 phosphorylates the CTD-Ser2 (Bowman and Kelly, 
2014; Krishnamurthy et al, 2004; Zhang et al, 2012b). This presence of CTD-Ser2P allows the 
recruitment of the cleavage and polyadenylation complex to the pre-mRNA (Lunde et al, 2010). 
The CTD-Ser2P is next removed by Fcp1 and the dephosphorylated Pol II can begin a new 
cycle (Cho et al, 2001). 
There are two alternative models for transcription termination and release of Pol II from the 
DNA (Briand, 2015). The allosteric model (Figure 3) suggests that the detachment of Pol II is 
mediated by conformational changes and by interaction with termination factors like Pcf11 
(Briand, 2015). Indeed, Pcf11, a cleavage and polyadenylation factor, is able to disassemble the 
Pol II elongation complex by linking the CTD-Ser2P and the nascent RNA forming a bridge 
between them. When the polymerase reaches the poly(A)-signal, the CTD changes its 
conformation, Pcf11 accompanies the CTD, generating some pressure on the nascent RNA. 
This pressure disrupts the duplex formed between the transcript and the DNA template leading 
to the dissociation of the elongation complex (Zhang et al, 2005). In the second model, the 
torpedo model (Figure 4), the cleavage of the pre-mRNA is required. This cleavage exposes an 
uncapped 5’ PO4 extremity which can serve as the substrate for the exonuclease XRN2. XRN2 
thus degrades the left-over RNA, moves towards the polymerase and disassembles the 
elongation complex (Briand, 2015; Luo et al, 2006). This model is supported by studies 
showing that the exonuclease Rat1 (yeast homolog of XRN2) is located at the end of protein-
coding genes, or that cells deleted for Rat1 show a termination defect (Kim et al, 2004). 
However, this model has been challenged by reports that termination can occur without pre-
mRNA cleavage. Indeed, in yeast, a mutant of Pcf11 has cleavage defect but the termination is 
not affected (Luo et al, 2006). Consequently, a third model is proposed, the hybrid allosteric-
torpedo model because neither the Pol II conformational modifications nor the RNA 
degradation by Rat1 is sufficient to induce the termination. This new model encompasses the 
two others and is based on the discovery that Rat1 promotes the recruitment of 3’ end processing 
factors like Pcf11 at the poly(A)-site. In this hybrid model, Rat1 is part of the cleavage and 
polyadenylation complex and this complex is responsible for the pre-mRNA cleavage, the left-
over RNA degradation and the Pol II conformational changes causing the release of the 
elongation complex (Briand, 2015; Luo et al, 2006). 
 
 
Figure 5: Hermaphrodite reproductive system. The oocytes arise by meiosis from a syncytim of undifferentiated germline
cells. They are fertilized by passing through the spermatheca and the newly formed eggs develop into the uterus before being
laid by the egg-laying apparatus (adapted from Mukhopadhyay and Tissenbaum, 2007).
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2. The nematode C. elegans 
2.1. Origins of C. elegans  
C. elegans was introduced in genetic laboratories by Sydney Brenner in 1963. At that time, 
the DNA structure had just been discovered and nothing was known about how the genes 
controlled the development of a multicellular organism. Brenner was thus looking for an animal 
with which he could answer the question “How genes might specify the complex structure 
found in higher organisms” (Brenner, 1974). To solve this problem, he wanted to study the 
nervous system of an animal with a quite simple neuronal system and handy to manipulate. 
After some investigations, he chose the nematode C. elegans (Brenner, 2003; Couillault and 
Kurz, 2010). 
 C. elegans was first described by Maupas in 1900 (Nigon and Félix, 2018) and first used 
in laboratories by Dougherty and Calhoun in 1957 (Sterken et al, 2015). In those days, there 
were two C. elegans strains. One strain, Bergerac was isolated in Lyon by Nigon and the other 
one, Bristol, was isolated near Bristol by Staniland in 1956 (Ferris and Hieb, 2015). The two 
strains are very different. The Bergerac strain exhibits a high spontaneous mutation frequency 
due to the presence of a high copy number of the TcI transposon and is also temperature-
sensitive. Indeed, they become sterile when cultivated at temperatures above 18°C (Riddle et 
al, 1997). This explains why most studies using nematodes are made with the Bristol strain and 
why Dougherty and Calhoun imported this strain in their laboratory in 1957. Concurrently, 
Brenner unsuccessfully tried to isolate C. elegans from his own garden. He thus requested the 
nematode from Dougherty who sent it to him. Brenner called this strain N2 because it was his 
second attempt to establish a C. elegans line (Sterken et al, 2015).  
Today the Bristol N2 strain is used as the wild-type strain in thousands of laboratories. 
 
2.2. C. elegans generalities 
C. elegans is a transparent nematode, 1 mm in length when adult, that lives in rotting fruits, 
rotting plants and in the compost where he feeds on bacteria (Frézal and Félix, 2015). It exists 
mainly as a hermaphrodite organism although male arises at low frequency (<0.2%) (Corsi et 
al, 2015). It is an eutelic organism meaning that it has a fixed number of cells, namely 959 
somatic cells for the hermaphrodite worm and 1031 for the male (Wood, 1988). Of these 959 
cells (or 1031), 302 are neurons that make more than 7000 chemical synapses and gap junction 
connections. It explains why C. elegans is widely used in neurobiology (Corsi et al, 2015). The 
remaining cells constitute the epidermis, the muscles, the digestive system, and the reproductive 
system. The epidermis, composed of syncytial cells, forms the outer epithelial layer and secretes 
a protective layer composed of collagen, lipids, and glycoproteins called cuticle. The cuticle 
determines the shape of the body, protects the nematode and provides anchoring points for 
mononucleated muscle cells forming the body-wall muscles, responsible for animal 
movements. In addition to the body-wall muscles, C. elegans has pharyngeal muscles, vulval 
muscles, and anal muscles (Corsi et al, 2015). The pharyngeal and anal muscles accompanied 
by neurons form the pharynx and the anus, which are part of the digestive system with the 
mouth and the intestine (Corsi et al, 2015). The vulval muscles are part of the reproductive 
system, which is different between the hermaphrodite and the male organisms. The 
hermaphrodite reproductive system is divided into three parts (Figure 5), the somatic gonad, 
the germline cells, and the egg-laying apparatus. The somatic gonad, located alongside the 
Figure 6: C. elegans embryonic development. The embryonic development is composed of six steps, the
proliferation, the gastrulation, the metamorphosis, the elongation, the quickening and the hatching (Wormatlas).
Figure 7: C. elegans life cycle. In its normal life cycle, C. elegans has four larval stage and one reproductive adult stage.
However, under bad conditions such as starvation, high temperature or overcrowding, C. elegans has an alternative life
cycle. They become dauer worms which are more resistant to hard conditions. It also exits a third possible life cycle
called the L1 arrest meaning that worms stop their development in their first larval stage. This happens when L1 larvae
hatch in absence of food (adapted from Wormatlas).
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intestine, consists of two U-shaped tubes and is composed of the distal tip cell (DTC), which is 
a single somatic cell constituting a cap over the gonad, the sheath cells overlying the germ cells, 
the spermatheca containing the sperm and the uterus. The germline cells represent a syncytium 
of undifferentiated cells located near the DTC and generating the oocytes through meiosis. 
These oocytes are fertilized by passing through the spermatheca and the newly formed eggs 
develop into the uterus before being laid by the egg-laying apparatus composed of the vulva, 
neurons, and muscles. The male reproductive system consists of a single U-shaped gonad that 
connects to a seminal vesicle stocking the sperm. The vas deferens next conducts the sperm to 
the cloaca in the tail of the worm (Corsi et al, 2015; Lints and Hall, 2009).  
 
2.3. C. elegans life cycle 
2.3.1. Normal life cycle 
Right after the fertilization of the oocyte, an impermeable eggshell is formed around the 
zygote allowing it to develop independently of the adult. Despite this eggshell, the eggs stay 
inside the uterus and the first phase of the embryogenesis begins (Figure 6). It is the proliferation 
step where cells undergo stereotyped division. They are all similar in their cytoplasmic contents. 
In addition, some cells undergo apoptosis and some migrate away from their sister cells. This 
is called “global cell sorting”. At approximately 30 cells, the eggs are laid, the second step of 
the embryogenesis, the gastrulation, begins and the proliferation keeps on. The gastrulation 
allows, by “global cell sorting”, the formation of functional cell groups and of the ectoderm, 
endoderm, and mesoderm. The next stage is the morphogenesis where cells become specialized 
and tissues are formed. The elongation and the quickening next take place. These are the steps 
where the embryos elongate to look like a worm (comma shape to 3 fold shape) and where 
muscle movement can be seen. The last step is the hatching (Hall et al, 2017). The released 
larvae (L1) will pass through three other larval stages (L2, L3, and L4), marked by the 
progressive development of the reproductive system, before becoming reproductive adults 
(Figure 7). These adults will finally lay eggs until they have utilized all their sperm 
(approximately 3 days) (Corsi et al, 2015). 
2.3.2. The dauer stage 
Under starvation, high temperature or overcrowded population, the L1 larvae follow an 
alternative cycle to become dauer worms (Figure 7). Dauer worms are distinct from L2 or L3 
larvae. Indeed, they are thinner and possess a cuticle resistant to hard conditions. This cuticle 
surrounds all the worm including the mouth, preventing it from feeding. Dauer worms can 
survive for months and can search for food by standing on their tail and attaching to insects and 
vertebrates which transport them to a suitable environment. This comportment is called 
nictation. When they find their new environment, they molt and resume their development from 
the L4 stage (Corsi et al, 2015; Lee et al, 2012).  
2.3.3. The L1 arrest 
In C. elegans, there is another alternative cycle, the L1 arrest (Figure 7). This arrest is 
completely different from the dauer stage because the worms’ morphology doesn’t change. 
Indeed, nematodes just stop their development in their first larval stage and do not reach the L2 
stage (Baugh, 2013). This alternative state occurs when embryos hatch in the absence of food 
due to a perturbation of the insulin-like IGF-1 pathway. Indeed in the presence of food, nutrients 
are detected by chemosensory and other neurons, which leads to the production of Insulin-Like 
Figure 8: Cis-splicing and trans-splicing. In cis-splicing, the 5’ splice site (5’ss) and the 3’splice site (3’ss) are linked by the
spliceosome to join two exons (light blue square) from the same pre-mRNA molecule. In trans-splicing, the first exon from the pre-
mRNA is joined with an exon from a non-coding RNA (the SL RNA). This SL RNA contain a TMG cap (green circle with a T), an
exon called the spliced leader (dark blue square), and a 5’ splice site (5’tss). The trans-splicing thus excises the long outron of the
pre-mRNA and joins the spliced leader with the TMG cap to the first exon of the mRNA (adapted from Lasda and Blumenthal,
2011).
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Peptides (ILPs). These ILPs activate the Insulin-Like Receptor called DAF-2. The pathway 
downstream of the activation of DAF-2 and mediated by the PI3K leads to the expression of 
genes involved in worm postembryonic development. By contrast, when no nutrients are 
available, DAF-2 stays inactive leading to an L1 arrest (Kaplan and Baugh, 2016). L1 arrested 
larvae are able to survive for 4 weeks due to the expression of genes involved in stress resistance 
and can resume the normal life cycle when food is available (Baugh, 2013). 
 
2.4. C. elegans genome 
2.4.1. Generalities 
C. elegans is a diploid organism and has six pairs of chromosomes. He has five autosomal 
chromosomes (I, II, III, IV, and V), and one sexual chromosome (X). As already said, C. 
elegans exists in two sex types. The hermaphrodites possess two X chromosomes (XX) but 
males possess only one X chromosome (XO). This results from the non-disjunction of the X 
chromosomes pair during gametogenesis (Corsi et al, 2015).  
All of the C. elegans chromosomes are holocentric meaning that they don’t have traditional 
centromeres. Indeed, the entire length of the chromosome act as the centromere and during the 
mitosis, the spindle microtubules attach along the whole length of the chromosome. This feature 
allows the formation of extrachromosomal DNA array which can be inherited by the progeny 
(Corsi et al, 2015). This is relevant during transgenesis as these arrays are not always easily 
distinguished from genomic insertions. 
The particularity of the nematode’s genome is the organization of approximatively 15% of 
genes in operons and the existence of a process called trans-splicing (Corsi et al, 2015). 
2.4.2. Operons and trans-splicing 
The C. elegans genome counts 1250 operons. Operons are clusters of genes under the 
control of a single promoter. In bacteria, genes in operons are usually part of the same pathway 
but it is not necessarily the case for nematodes. Indeed, the polycistronic pre-mRNA is co-
transcriptionally processed into monocistronic mRNAs. This processing is made by the 
polyadenylation of the 3’ end of the upstream gene and the trans-splicing of the 5’ end of the 
downstream gene. The trans-splicing is the joining of two RNA exons from two different RNA 
molecules. This is distinct from normal or cis-splicing, which is the joining of two RNA exons 
from the same RNA molecule (Figure 8) (Blumenthal et al, 2018). 
In cis-splicing (Figure 8), two exons from the same pre-mRNA are joined by the action of 
the spliceosome, catalyzing two transesterification reactions. The spliceosome consists of small 
nuclear ribonucleoproteins (snRNPs) and non-snRNP proteins. Each snRNP called U1, U2, U5, 
and U4/U6 consists of a small nuclear RNA (snRNA) (or two in the case of U4/U6), seven 
proteins Sm and a variable number of particle-specific proteins. Spliceosome assembly occurs 
by the ordered interaction of the snRNPs and other factors with the 5’ splice site (5’ss), the 
branch site, the polypyrimidine tract, and the 3’ splice site (3’ss) (Will and Lührmann, 2006).  
In trans-splicing (Figure 8), one exon belongs to the pre-mRNA and the other belongs to a 
specialized non-coding RNA (SL RNA). This SL RNA contains a 5’ trimethylguanosine 
(TMG) cap, a 22 nucleotide exon called the spliced leader (SL) and an Sm binding site. 
Consequently, the SL RNA also forms snRNP by getting together with Sm proteins. The 
difference with cis-splicing is that the SL RNA is consumed during the splicing reaction. 
Figure 9: SL2 trans-splicing process. The trans-splicing of genes in position 2 and over in operons is realized by the SL2
snRNP. This complex interacts with the CstF factor involved in the cleavage and polyadenylation of the pre-mRNA from
the upstream gene. It is this specific interaction which allow to recruit the SL2 snRNP and not the SL1 snRNP. In addition,
a U-rich element is necessary because the SL2 snRNP binds to this sequence (adapted from Evans et al, 2001).
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Indeed, the SL RNA contains a 5’ splice site allowing the SL to be transferred to the pre-mRNA. 
The main function of the trans-splicing is the protection of the 5’ extremity of pre-mRNAs 
from operons genes. Indeed, eukaryotic pre-mRNAs are capped by the capping machinery but 
genes within operons are not recognized by the usual capping machinery. Consequently, their 
pre-mRNAs are protected by the 5’ TMG cap donated with the SL. The trans-splicing has also 
other functions such as the removal of outrons (5’ non-coding sequence of the pre-mRNA). 
This outron probably contains AUG codons so if it is not removed, there is a risk that the 
ribosome begins the translation process by using one of these out-of-frame start codons. 
Therefore, the trans-splicing, by taking off the outron allows being sure that only the correct 
AUG codon is used (Lasda and Blumenthal, 2011).  
C. elegans has two distinct SL RNAs called SL1 RNA and SL2 RNA. They share similar 
features, they both possess the TMG cap and both associate with Sm proteins. However, the 
SL1 RNA is used to trans-splice single genes and the genes in position 1 within operons while 
SL2 RNA is specific for the trans-splicing of genes located further in operons (position 2 and 
over) (Lasda and Blumenthal, 2011). Consequently, a mechanism that regulates the selection 
of the SL2 RNA should exist (Figure 9). Several studies suggest that the trans-splicing of the 
pre-mRNA from the downstream gene is coupled with the polyadenylation of the pre-mRNA 
from the upstream gene. Indeed, the SL2 snRNP interacts with the 3’ end processing factor, 
CstF (Cleavage stimulatory Factor which binds to a U/GU-rich element) (Evans et al, 2001). 
CstF also interacts with CPSF (Cleavage and Polyadenylation Specificity Factor) - which binds 
to the Polyadenylation Signal (PAS) AAUAAA - forming a link between CPSF and the SL2 
snRNP (Murthy and Manley, 1995). In addition, a U-rich element is necessary for the SL2 
trans-splicing probably because the SL2 snRNP binds to this U-rich element (Huang et al, 
2001).  
 
2.5. C. elegans genome engineering 
Genetic mutations arise spontaneously at a low level in the process of evolution. In the lab, 
however, they can be induced by several techniques to create mutant organisms used in genetics 
to study gene function. 
2.5.1. Genome-wide mutagenesis 
Historically, mutant organisms were produced using mutagenic agents targeting the whole 
DNA and thus inducing mutations in the entire genome. These mutagenic agents are diverse 
chemical products, high-energy radiations or transposons. The transposon-mediated technique 
consists of disrupting genes by the random insertion of a transposon after the action of the 
appropriate transposase. Indeed, by crossing one C. elegans strain (EG1470) expressing the 
exogenous transposon Mos1 with one strain (EG2762) expressing the transposase, a hybrid 
strain, where the transposon is randomly inserted into the genome, is obtained. This hybrid 
strain has disrupted genes that can give interesting phenotypes (Kutscher and Shaham, 2014).   
2.5.2. Gene-targeted mutagenesis 
The previous genome-wide mutagenesis is generally used for forward genetic screens. By 
contrast, reverse genetic screens are usually performed using gene-targeted mutagenesis. 
Techniques based on homologous recombination between exogenous DNA and the organism’s 
genome were thus developed in order to achieve mutant organisms with mutations only in a 
locus of interest. (Kutscher and Shaham, 2014).  
Figure 10: The MosSCI technique. The MosSCI technique is based on the previous insertion of the exogenous Mos1 transposon
in intergenic regions of the genome. With the injection of the appropriate transposase, the transposon is removed leading to a
double-strand DNA break. This break is repaired by homologous recombination with an injected repair template containing
homologous sequence to the extremity of the break along with a positive selection marker, usually unc-119(+) (adapted from
Frøkjaer-Jensen et al, 2008).
Figure 11: The CRISPR/Cas9 technique. The endonuclease Cas9 identifies its target DNA by binding to the PAM
motif and after by hybridization of the crRNA with its complementary DNA. When Cas9 has identified its target, it
generates a double-strand DNA break (Max-Planck-Gesellschaft website).
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Homologous recombination was widely used in yeast but this method is not very effective 
in C. elegans. Indeed, the injection of exogenous DNA into the nematode generates large 
extrachromosomal arrays or random integration into the genome (Evans, 2006). However, it 
was demonstrated that in C. elegans, a DNA break generated by the excision of the endogenous 
Tc1 transposon can be repaired by homologous recombination. This suggests that 
recombination functions in nematodes if a DNA double-strand break is previously induced 
(Plasterk and Groenen, 1992). There are two methods based on the induction of a break into the 
worm’s genome and the reparation of this break by recombination, the transposon-based 
technique and the CRISPR/Cas9 technique (Kutscher and Shaham, 2014). 
The transposon-based technique is based on the previous insertion of Mos1 transposon near 
or in the gene of interest. Approximately, 13000 loci were tagged with the transposon by the 
NemaGENETAG consortium. Consequently, when the desired strain is chosen among the 
13000, the injection of the Mos1 transposase generates a DNA break which is repaired by 
homologous recombination with an injected repair template. This technique is called MosTIC 
(Mos1-excision Transgene-Instructed gene Conversion) and allows to introduce point 
mutations, deletions or insertions near or in a locus of interest (Kutscher and Shaham, 2014). 
Similarly, another technique, the MosSCI (Figure 10) (Mos1 mediated Single Copy Insertion) 
is also based on the previous insertion of the Mos1 transposon, on the action of the transposase 
and on the reparation of the generated break by homologous recombination. The difference with 
the MosTIC is that in the MosSCI, the Mos1 transposon is situated in intergenic regions 
allowing the incorporation of a stable mutated copy of a gene. Because the insertion does not 
occur at the endogenous locus, the transgene has to contain the promoter and the terminator of 
the gene of interest (Frøkjaer-Jensen et al, 2008).  
To identify mutants for the insertion of the desired mutation, a positive selection marker is 
added in the repair template. This marker is usually unc-119(+) (Figure 10). It is a rescuing 
marker. Indeed, usually, worms that are used for MosTIC or MosSCI have a mutation in the 
unc-119 gene leading to paralysis. Consequently, by placing the rescuing marker in the repair 
template, it will be incorporated into the genome along with the gene of interest leading to non-
paralyzed worms. These non-paralyzed worms normally carry the desired modification 
(Frøkjaer-Jensen et al, 2008). 
The other method, the CRISPR/Cas9 technique is also based on the presence of a double-
strand DNA break which is repaired by homologous recombination with a donor repair template 
(Dickinson and Goldstein, 2016). The difference with the transposon-based technique is that 
the break is not induced by the removal of a transposon but by the action of the endonuclease 
Cas9. Indeed, the Cas9 endonuclease can be guided to the desired locus (Figure 11) by the 
action of a single guide RNA molecule (sgRNA) composed of a crRNA (CRISPR RNA), which, 
by base-pairing with the genome, determines the target specificity and a tracrRNA (trans-
activating CRISPR RNA), which activates Cas9. In addition to this base-pairing, Cas9 identifies 
its target DNA by binding to a trinucleotide sequence (usually an NGG) called the Protospacer-
Adjacent-Motif (PAM). Once Cas9 has recognized its target (by the identification of the PAM 
and the hybridization of the crRNA with the genome) it generates a double-strand DNA break. 
This break can be repaired by homologous recombination with a donor repair template 
containing homologous sequences flanking the break (Dickinson and Goldstein, 2016). With 
this technique, punctual mutations, insertions or even replacement of a part of a gene can be 
generated (Dickinson and Goldstein, 2016).  
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It exists two main screening strategies after a CRISPR/Cas9 experiment to distinguish 
mutant worms. The first strategy is the use of an antibiotic resistance gene.  Indeed the repair 
template can contain, in addition to the desired mutation and the homology sequences to the 
genome, a gene conferring resistance to an antibiotic. Thereby, if the CRISPR/Cas9 experiment 
works, the antibiotic resistance gene will be integrated into the organism’s genome and only 
mutant worms will survive to the exposition to the antibiotic (Dickinson and Goldstein, 2016). 
In C. elegans, several antibiotics can be used, such as blasticidin, hygromycin, neomycin 
(Dickinson and Goldstein, 2016) or puromycin (Semple et al, 2010). The second strategy is 
called the co-CRISPR strategy. This technique consists of editing two loci during the same 
microinjection experience. It means that in addition to Cas9, the crRNA, the tracrRNA and the 
repair template to mutate the desired locus, another crRNA with another repair template are 
injected to mutate a gene generating a visible phenotype. Consequently, there is a good chance 
that worms expressing the visible phenotype will be positive for the desired mutation 
(Dickinson and Goldstein, 2016). Several genes can be used such as unc-58, unc-109 or unc-43 
which induces worms paralysis when edited or rol-6, sqt-1 or dpy-10 which generates a roller 
phenotype meaning that worms roll on themselves (Arribere et al, 2014). dpy-10 and sqt-1 have 
one main advantage compared to others, they confer a different phenotype if the mutation is 
made on only one allele (roller phenotype) or on the two copies of the gene (dumpy phenotype 
meaning that worms are shorter than wild-type). It is a benefit because as C. elegans is a 
hermaphrodite organism, worms carrying the desired mutation but lacking the screening 
mutation can be recovered in the progeny of a roller heterozygote worm but not in the progeny 
of a dumpy homozygote one. Therefore, generally dumpy worms are left out and scientists work 
with roller worms (Arribere et al, 2014). 
 
3. Gene-specific function of CDK12  
Regarding the CDKs mediated CTD phosphorylation during the transcription cycle, it was 
though for a long time that CDKs were required for viability. However, even if CDK9 is indeed 
essential, for example in C. elegans or D. melanogaster (Shim et al, 2002; Eissenberg et al, 
2007), CDK12 seems to act in a more gene-specific manner and thus to be important for the 
expression of only a subset of genes.  
3.1. Lsk1 in S. pombe 
Previous work in the lab (Coudreuse et al, 2010) showed that in Schizosaccharomyces 
pombe, the absence of CTD-Ser2P resulting from the deletion of the Lsk1 kinase (the S. pombe 
homolog of CDK12) or from the replacement of all CTD-Ser2 by alanine (CTD-S2A), only 
barely affects vegetative growth. They also showed by ChIP experiment that as expected, in 
wild-type yeast, the CTD-Ser2P increase towards the 3’ region of most coding genes. However, 
a subset of 150 genes does not follow this pattern and the CTD-Ser2P is already present 
upstream of the coding region and across the full length of the transcript. Among those genes, 
the master regulator of differentiation, ste11. Ste11 is required under nitrogen starvation to stop 
the vegetative growth (mitotic cell cycle) and induced sexual differentiation (mating and 
meiosis) (Van Werven and Amon, 2011). Consequently, Coudreuse and co-workers quantified 
the expression level of ste11 by qRT-PCR during nitrogen starvation. They discovered that the 
level of ste11 mRNA increases in a wild-type yeast while in mutants deleted for the CTD-Ser2P, 
there is no induction of ste11. These mutant yeasts present a strong phenotype under starvation, 
Figure 12: The analog-sensitive kinase. The Shokat analog-sensitive kinase allows to specifically inhibit a desired
kinase without impacting on the others. It consists in enlarging the catalytic pocket of the desired protein in order to use
an inhibitor (enlarged ATP analog) targeting only this kinase. (A). Wild-type (WT) kinase are not impacted by the
presence of the inhibitor. (B). In the absence of inhibitor, the as- kinase (mutant) has normal activity. (C). In the presence
of the inhibitor, the as- kinase can not play its role (Alaimo et al, 2001).
.. .
  
17 
 
they are unable to mate. In this study, they consequently propose that the phosphorylation of 
the CTD-Ser2 is not essential for general transcription but is important for a subset of genes 
implicated in a certain cellular response, here the sexual differentiation (Coudreuse et al, 2010).  
 
3.2. Cdk12 in D. melanogaster 
In D. melanogaster (Li et al, 2016), the action of Cdk12 is dispensable for viability or for 
general transcription as its deletion does not compromise the viability and does not affect the 
expression of housekeeping genes. However, Cdk12 is required for the expression of a subset 
of genes involved in stress response, like the transcription factor, Nrf2. In a wild-type organism, 
treated with paraquat (a compound which stimulates the production of superoxide radical), the 
expression of Nrf2 target genes increases. However, in mutants deleted for Cdk12 and treated 
with paraquat, the expression of these genes does not increase. In addition, flies with Cdk12 
knockdown are much more sensitive to stressors than wild-type flies. For example, they died 
more quickly than control flies when exposed to an oxidative stressor. This suggests that Cdk12 
is not necessary for the transcription of every Pol II-transcribed gene but is rather important for 
a small subset of genes implicated in the stress response pathway (Li et al, 2016).  
 
3.3. CDK-12 in C. elegans 
Inhibiting CDK-12 is quite difficult because although RNAi is possible, it has one main 
disadvantage, the effect can be inherited but it is not permanent and often not fully penetrant 
(Conte Jr et al, 2015). The solution is to chemically inhibit the kinase. However, most of the 
existing inhibitors target all kinases. Shokat and his co-workers thus developed a method to 
override the use of such inhibitors. This is the creation of the Shokat analog-sensitive kinase 
(as- kinase) (Figure 12) (Alaimo et al, 2001). This approach consists of the replacement, in the 
catalytic pocket of the desired kinase, of a bulky amino acid by a smaller one, enlarging the 
catalytic pocket. This mutation has no impact on the kinase without the action of an inhibitor. 
Indeed, the as- kinase can link the ATP and phosphorylate its substrate. However, in the 
presence of an inhibitor, which consists of an enlarged ATP analog able to bind the modified 
pocket but not the wild-type one, the as- kinase cannot phosphorylate its substrate (Alaimo et 
al, 2001). In the lab, a worm strain expressing an analog-sensitive CDK-12 (cdk-12as mutant) 
was created by replacing a phenylalanine by a glycine.  
The inhibition of CDK-12as in C. elegans induced an L1 arrest accompanied by a decrease 
in the CTD-Ser2P level. It means that the presence of CDK-12 and the CTD-Ser2P is not 
necessary for the embryonic development but is required after the hatching to drive the 
postembryonic development. To try to understand what is causing the L1 arrest, an RNAseq 
experiment was performed and it was found that the genes impacted by the absence of CDK-
12 are located in position 2 and over within operons, in other words, the genes that are trans-
spliced with the SL2 RNA, which was indeed shown to be markedly reduced. These genes are 
typically important for worm development.  
These results suggest that CDK-12 may be required for the SL2 trans-splicing. Considering 
that the SL2 snRNP interacts with the 3’ end processing factor, CstF (Cleavage stimulatory 
Factor) whose CstF50 subunit binds the CTD-Ser2P (Lunde et al, 2010), a reasonable model 
Figure 13: Suggested model to explain the L1 arrest caused by the inhibition of CDK-12as in C. elegans. (A). In
the presence of CDK-12, the CTD-Ser2 are phosphorylated (S2P) leading to the recruitment of the CstF factor. The
CstF factor next interacts with the SL2 snRNP (SL2 RNP) to allow the SL2 mediated trans-splicing. The mRNA from
genes in position 2 and over in operons are thus protected by the spliced leader 2 (SL2) accompanied by a 5’
trimethylguanosine (TMG) cap. (B). However, when CDK-12as is inhibited, the CTD-Ser2 are not phosphorylated
(S2), the CstF factor and the SL2 snRNP are not recruited and thus the mRNA from genes in position 2 and over in
operons are not protected and can be degraded by the exonuclease XRN-2.
.
.
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(Figure 13) is that upon CDK-12as inhibition, the level of CTD-Ser2P drops, which dissociates 
CstF and compromise the SL2 trans-splicing. 
This possibility is supported by the fact that RNAi previously performed by the lab targeting 
the exonuclease XRN-2 partially restored the normal worm development after CDK-12as 
inhibition. This suggests (Figure 13) that XRN-2 may be responsible for the degradation of the 
RNAs from genes in position 2 and over within operons when CDK-12as is inhibited.  
Our model recapitulating the current data (Figure 13) also implicates that following the 
action of XRN-2, a torpedo effect may occur, leading to the detachment of the polymerase and 
to the termination. Consequently, the amount of protein corresponding to the genes in position 
2 and over in operons is reduced at both the transcriptional and post-transcriptional levels, 
which results in a robust L1 arrest. It is now essential to challenge the model by initiating a new 
set of experiments. 
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Objectives of the work 
 
The inactivation of CDK-12 in C. elegans results in an L1 arrest while the previous 
embryogenesis occurs normally. Transcriptomic analysis has revealed that the transcription of 
a subset of genes localized in position 2 and over within operons and required for development 
is specifically downregulated. It is therefore likely that the phenotype observed results from a 
transcriptional defect. Nevertheless, when studying a kinase-substrate relation, it is important 
to show that the trans-mutant (CDK-12as) displays the same phenotype than the cis-mutant. 
Therefore, the first objective of this work is to generate a C. elegans strain where each CTD-
Ser2, the target of CDK-12, is replaced with an Alanine (a non-phosphorylable amino acid) 
(CTD-S2A strain). Using this strain, we aim to assess whether the L1 arrest observed upon 
CDK-12 inhibition is indeed CTD-dependent. This confirmation is particularly important as it 
has been shown that CDK-12 plays an unrelated role in the translation initiation process (Choi 
et al, 2019; Coordes et al, 2015). 
Considering that the inactivation of CDK-12 mimics the well-documented L1 arrest 
resulting from hatching in the absence of food, we hypothesized that the recruitment of CDK-
12 to operons is regulated by environmental cues including food availability. In C. elegans, it 
is known that the insulin-like IGF1 pathway connects nutrient availability to development 
through the Insulin-Like Receptor, DAF-2 and its downstream pathway mediated by the 
PI3K/Akt or by the Ras/MAPK (Templeman and Murphy, 2018). Indeed, while less well 
understood, it seems that the Ras/MAPK pathway is also connected downstream of DAF-2 
(Nanji et al, 2005). We thus postulate that CDK-12 could be regulated by one of these two 
pathways (PI3K/Akt or Ras/MAPK), which is reminiscent of previous work of our laboratory 
in fission yeast (Materne et al., 2015) that has shown that the gene-specific recruitment of Lsk1 
(CDK-12 yeast homolog) requires a MAP-kinase dependent phosphorylation of an N-terminal 
extension of the kinase conserved in nematodes (Materne et al, 2015). Therefore, the second 
aim of this work is to construct and purify a tagged version of CDK-12 from a synchronous 
worm population hatched in the presence or absence of food and analyze the phosphorylation 
status of the kinase by mass spectrometry.   
 
 
 
 
 
 
 
 
Figure 14: Microinjection in C. elegans. The injection is performed in the gonad syncytium (adapted from Daniel et al, 2013).
Figure 15: Microinjection training. (A). C elegans muscles. myo-2 is expressed in pharyngeal muscles while myo-
3 is expressed in body-wall muscles, vulval muscles and anal muscles (adapted from Fox et al, 2007). (B). F1 worms
expressing either myo-2::GFP or myo-3::GFP after microinjection of parental worms.
.
.
Figure 16: Sequence of the genomic CTD, CTD-S2A and
CTD-S2S. (A). Protein sequence of the wild-type genomic
CTD (adapted from Uniprot website), the CTD-S2S and the
CTD-S2A. The protein sequence of the CTD-S2S is the same
as the genomic CTD. However, the protein sequence of the
CTD-S2A differs from the genomic CTD because of the
presence of alanine instead of serine in position 2 (blue). The
only exception is the CTD-Ser2 of the fourth repeat (red)
which is conserved because it is not followed by a proline and
thus can not be phosphorylated by CDK-12. (B). Cartoon of
the DNA sequence coding for the genomic CTD, the CTD-S2S
and the CTD-S2A. Contrary to the genomic CTD, the
sequence coding for the CTD-S2A or the CTD-S2S lack
introns and possess silent mutations (꙳).
. .
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Results  
1. Microinjection training 
Transgenesis is performed in C. elegans by microinjecting in the gonad arm of a worm all 
the necessary components of CRISPR-mediated gene targeting (Figure 14). Because all 
germline nuclei share the same cytoplasm, the procedure targets a lot of futures oocytes and 
thus increases the heritability percentage by targeting the germline syncytium (Mello et al, 
1991). Consequently, the parental injected worm is not mutated but its descendants (F1) are, 
most often on a single allele inherited from the oocyte. Because C. elegans is hermaphrodite, 
about 25% of the F2 should be homozygous for the mutation. 
The injection procedure is not straightforward and requires practice. As I had no 
microinjection experience, I trained by injecting plasmids expressing myo-2::GFP and myo-
3::GFP. myo-2 codes for myosin 2 and is expressed in pharyngeal muscles while myo-3 codes 
for myosin 3 and is expressed in body-wall muscles, vulval muscles and anal muscles 
(WormBase website). If the injection correctly targeted the germline rather than the intestine, 
which is not unusual, the progeny of a given injected worm will appear green under a 
fluorescence microscope (Figure 15). On average, 30% of the injected worms had F1 
fluorescent descendants. Based on these results, I moved on to the generation of new mutants. 
2. Does the mutation of the CTD-Ser2 recapitulate the inhibition of 
CDK-12? 
2.1. Design of the CTD-S2A or CTD-S2S versions to integrate 
In C. elegans, the CTD serine in position 2 is conserved in 33 out of the 42 repeats 
composing the CTD (Uniprot website) (Figure 16A). To test if the CTD-Ser2 is the genuine 
target of CDK-12 explaining the phenotype of the inactivation of the kinase, we ordered a DNA 
fragment whose sequence encodes for a version of the CTD where every CTD-Ser2 is replaced 
by an alanine (CTD-S2A) except the CTD-Ser2 found within the fourth uncanonical repeat, 
which is followed by a methionine rather than a proline (Figure 16A). Indeed CDKs are proline-
directed serine/threonine kinases (Malumbres, 2014) and that specific serine is not a predicted 
substrate of CDK-12.  
The sequence coding for this CTD-S2A was synthesized by Eurofins Genomics but, 
because of the repetitive nature of the CTD (even at the DNA level), the DNA sequence had to 
be adapted and codon-optimized from the genuine sequence (wild-type worms) to be 
synthesizable. In addition, in order to minimize its size, the 3 endogenous introns were removed 
(Figure 16B). 
Considering that these constraints could have unanticipated effects, another sequence was 
synthesized by Eurofins Genomics, the CTD-S2S, following the same strategy but retaining 
serines in position 2 (Figure 16A and B). This sequence, therefore, serves as a control. 
 
2.2. Construction of a strain expressing the CTD-S2A or CTD-S2S  
To create the C. elegans strains where the CTD-S2A or CTD-S2S replaces the endogenous 
locus, we used the CRISPR/Cas9 method. There are two main ways to deliver the protein Cas9 
..
.
.
.
Figure 17: Construction of a strain expressing the CTD-S2A or CTD-S2S. (A). PCR reactions to obtain the repair template with
the mutated CTD (either the CTD-S2A or the CTD-S2S). The first PCR is made with a set of primers with no homology arms to the
genome (short primers) and the second is made with a set of primers with 160bp homology arms (long primers). The two PCR products
are melted and reannealed to generate the repair mixture composed of four molecules of which two have single-strand overhangs. (B).
Two crRNAs were designed to bring Cas9 on each side of the sequence coding for the CTD. Two double-strand DNA breaks are then
generated, and a homologous recombination takes place with the injected donor template to integrate the sequence coding for the
mutated CTD (CTD-S2A or CTD-S2S) instead of the one coding for the genomic CTD. (C). The first crRNA is designed to bind just
before the beginning of the CTD and the second crRNA is designed to bind in the CTD, just before the stop codon of ama-1. (D) (E).
The repair template created by the two different PCR reactions, contains the mutated CTD (green) and homology sequences to the
genome (blue) generated by the long primers used in the second PCR reaction. To prevent Cas9 from cutting the modified genome in
the beginning of the CTD, a mutation to mutate the PAM (red) was introduced in the forward long primer. To prevent Cas9 from
cutting the modified genome in the end of the CTD, the silent mutations in the sequence coding for the mutated CTD and introduced by
Eurofins Genomics (red) are enough.
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and the sgRNA into the gonad, either as plasmid-borne or as a preassembled Cas9 
ribonucleoprotein (RNP) composed of the purified Cas9 protein and the tracrRNA with crRNA 
synthesized in vitro. In addition, two types of repair templates can be used, a linear fragment or 
a circular repair plasmid (Dickinson and Goldstein, 2016).  
In a first attempt to generate the mutant strains, we decided to use a linear repair template 
and two preassembled Cas9 RNPs, one with a crRNA targeting the upstream region of the DNA 
sequence encoding the CTD and one with a crRNA targeting the downstream region (Figure 
17B and C). 
The two crRNAs were designed using the IDT software, “Custom Alt-R CRISPR-Cas9 
guide RNA”. This software proposes a list of crRNA that can be used to target a desired region 
and gives for each crRNA the on-target score and the off-target score. The on-target score is an 
indication of the predicted activity of the crRNA and the off-target score is an indication of its 
specificity (Dickinson and Goldstein, 2016). Therefore, these scores have to be high (close to 
100). For the crRNA targeting the beginning of the CTD, the software gave a lot of possibilities 
so we chose the one that is the closest from the first codon of the sequence encoding the CTD 
because the Cas9 mediated cut has to be realized as close as possible to the place where the 
modification is desired (Dickinson and Goldstein, 2016). This crRNA has an on-target score of 
67, an off-target score of 99 and binds before the sequence encoding the CTD (Figure 17C). 
For the second crRNA, targeting the end of the CTD, the same approach was followed and we 
chose to work with a crRNA with an on-target score of 73, an off-target score of 83 and that 
binds within the sequence encoding the CTD just before the stop codon of ama-1 (Figure 17C). 
The linear repair template was produced by two independent, yet largely overlapping PCR 
reactions from the plasmid produced by Eurofins Genomics (Dokshin et al, 2018) (Figure 17A).  
The first PCR used primers with no homology arms to the C. elegans genome (short primers) 
and the second PCR used primers with 160bp homology to the genome locus (long primers). 
The two PCR products were melted and reannealed to obtain a mixture of four molecules of 
which two have single-strand overhangs. This mixture served as the repair template. We chose 
to work with single-stranded overhangs repair template because the work of Dokshin and co-
workers supports that it works better than a template with fully double-stranded homology arms 
(Dokshin et al, 2018).  
To make sure that Cas9 will not re-cut an already repaired locus, we introduced a silent 
mutation to change the PAM in the forward long primer used to amplify the repair template 
(Figure 17D and E). Consequently, after the cut and repair, the PAM will be mutated preventing 
Cas9 from recognizing its target in the 5’ region of the CTD. Indeed, even with a crRNA 
perfectly matching with the genome, Cas9 cannot bind to its target region without the PAM 
motif (Diskinson and Golsdtein, 2016). On the reverse primer, no mutations were necessary 
because the PAM is located within a region that is already strongly altered in the synthetic, 
mutated sequence, which is enough to prevent Cas9 from re-cutting the modified genome 
(Figure 17D and E).  
The mutant strain expressing the CTD-S2S was already obtained before I arrived in the lab, 
so we characterized it, but the CTD-S2A mutant had yet to be obtained. Therefore, we continued 
to inject C. elegans, using the co-CRISPR screening strategy mutating the dpy-10 locus as 
reporter. Indeed, by replacing the CGT trinucleotide (coding for an arginine) by a TGC (coding 
for a cysteine) in the dpy-10 locus (mutation dpy-10 (cn64)), the worms become roller (if 
. .
Figure 18: CTD-S2A screening. (A). CTD-S2A screening strategy. If the worm is wild-type (orange), no PCR product is amplified
because the sequence is too long. If the worm has the CTD-S2A (green), then a 1418bp PCR product is obtained. (B). Agarose gel
stained with ethidium bromide shows no CTD-S2A worms but worms expressing a deleted CTD (just over 500bp) (lanes 1, 2 and 4) and
worms expressing the genomic CTD because no PCR product is obtained (lanes 3 and 5). The lane “-“ is the negative control (F1 worm
from a non-injected parental) and the lane “+” is the positive control (worm expressing the CTD-S2S because the sequence coding for
the CTD-S2S or the CTD-S2A are the same length). The first single worm PCR protocol (see material and methods) was used.
Figure 19: The self-excising cassette (SEC) (A). Composition of the SEC. This cassette is composed of a visible marker, sqt-
1(d), a hygromycin resistance gene (hygR) and an heat-shock inducible Cre recombinase (hs::Cre). The SEC is flanked by two
LoxP sites which allow its removal by the Cre enzyme after its activation by heat shock. After the excision of the cassette, one
LoxP site remains within an intron (adapted from Dickinson et al, 2015). (B). Use of the SEC to generate fluorescent and 3-FLAG-
tagged protein. The plasmid that we can purchased contains the SEC with a fluorescent (FP) and a 3-FLAG tag flanked with ccdB
fragments. It is possible to replace these ccdB fragments by homology arms to the C. elegans genome to use the plasmid in a
CRISPR/Cas9 experiment in order to generate tagged proteins (Dickinson et al, 2015).
.
.
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heterozygous) or dumpy (if homozygous) (Arribere et al, 2014). However, the CTD-S2A strain 
was not obtained. Indeed, roller worms were obtained and were thus tested to assess the 
replacement of the genomic CTD by the CTD-S2A by single worm PCR using a set of primers 
flanking the CTD (Figure 18A). If the worm was not mutant (he had the genomic CTD), no 
PCR product was obtained because the fragment is too long to be amplified by this PCR 
reaction. However, if the worm was mutant (the CTD-S2A replaced the genomic CTD) a PCR 
product of 1418bp should have been obtained because the DNA sequence coding for the CTD-
S2A has no introns and is therefore shorter. All tested roller worms were negative for the 
mutation of the CTD but we obtained worms with a band just over 500bp (Figure 18B). We 
sequenced this PCR product and found that these worms were heterozygous for the expression 
of a deleted CTD (Figure S1). This means that the crRNAs can bind to the target DNA and that 
Cas9 can cut this DNA, however, the following repair process relies on non-homology end-
joining with no homology-based integration of the repair template.  
We thus decided to modify the method in order to obtain this strain. We thought of using a 
repair template with much longer homology arms to the C. elegans genome (2kb instead of 
320bp) in order to increase the probability of homologous recombination. We also wanted to 
change the way to screen potential mutant worms in order to limit false-positive (worms with 
the dpy-10 (cn64) mutation but not with the desired mutation). We, therefore, decided to use 
the screening method described by Dickinson and co-workers (Dickinson et al, 2015). In this 
paper, the authors introduce what they named a self-excising cassette (SEC) (Figure 19A). This 
SEC is composed of a hygromycin resistance gene, which is a selectable marker in C. elegans, 
and a Cre recombinase under the control of a heat-shock inducible promoter. In addition, the 
sqt-1(d) dominant allele (with a cysteine replacing an arginine) of the sqt-1 gene, which 
generates a roller phenotype is also present (Dickinson et al, 2015). The sqt-1(d) allele only 
confers a robust roller phenotype but no a dumpy one because, by contrast to the co-CRISPR 
strategy where the endogenous gene is mutated, a third (mutated) copy of sqt-1 is added while 
the endogenous alleles are intact. The sqt-1(d) allele, therefore, acts as a dominant-negative and 
this leads to a roller phenotype only (Dickinson et al, 2015).   
In their paper, Dickinson and co-workers used this cassette to generate fluorescent and 3-
FLAG tagged proteins. Indeed, they inject a mix of plasmids in C. elegans. The first plasmid 
of their mix contains the Cas9 gene, the second allows expression of the crRNA coupled with 
the tracrRNA and the third plasmid represents the repair template (Figure 19B) containing a 
fluorescent protein and a 3-FLAG merged to the SEC and flanked by 500-700bp homology 
arms (these homology arms are introduced by replacing the ccdB fragments in the starting 
plasmid by a Gibson Assembly). They screened mutant worms by first selecting hygromycin 
resistant worms and next by finding worms expressing the roller phenotype. Finally, once the 
wanted strain is obtained, the worms can be heat-shocked to induce the Cre recombinase, which 
will remove the SEC thanks to two LoxP sites flanking the cassette (Figure 19A). Therefore, a 
mutant that expresses a fluorescent and 3-FLAG tagged protein is obtained no longer containing 
the selection markers. The only disadvantage of this cassette is the residual presence of a LoxP 
site but that scare is located within a synthetic intron and will therefore not influence the 
produced protein sequence (Dickinson et al, 2015).  
In order to create the two mutant strains expressing the CTD-S2A or CTD-S2S (which is 
repeated here as a control), we followed the protocol of Dickinson and co-workers (Dickinson 
Figure 20: Construction of plasmids containing the crRNA and the tracrRNA. The plasmid pRB1017 is cut with BsaI to
generate four nucleotides overhangs. Two oligonucleotides (the forward and the reverse sequence coding for the crRNA) are
ordered and annealed. These oligonucleotides contain some more nucleotides (red) allowing their ligation in the cut plasmid. This
figure show the example for the crRNA targeting the beginning of the CTD to generate a C. elegans mutant strain expressing the
CTD-S2A or CTD-S2S (adapted from Arribere et al, 2014).
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et al, 2015) and used a mix of plasmids instead of the preassembled Cas9 RNPs and the linear 
repair template. 
The protocol requires the construction of two plasmids, designed to express one of the two 
crRNAs targeting the locus. We used the published pRB1017 plasmid (Arribere et al, 2014) 
(Figure 20). This plasmid already contains the DNA sequence corresponding to the tracrRNA 
preceded by 20 nucleotides flanked by sites for the restriction enzyme BsaI. Consequently, to 
introduce the sequence corresponding to the crRNA, we cut the plasmid with BsaI which 
generates 4 nucleotides overhangs. We next ordered two DNA oligonucleotides (the forward 
and reverse sequence corresponding to the crRNA) that we annealed. Each of these 
oligonucleotides contains in their 5’ and 3’ region, some nucleotides, complementary to the 
nucleotides overhangs generating by the cut of the plasmid by BsaI, allowing their ligation in 
the plasmid. By using this technique, the crRNA is precisely fused to the tracrRNA to form a 
complete sgRNA after transcription.  
The construction of the repair template was more challenging. Indeed, our goal is to replace 
the genomic sequence encoding the CTD by the CTD-S2S or CTD-S2A versions rather than 
tagging with a fluorescent protein or a 3-FLAG as described by Dickinson and co-workers 
(Dickinson et al, 2015). Consequently, a new more complex vector had to be constructed on 
the base of the Dickinson template (Figure 21).  
We first cloned a PCR-amplified 5’ CTD homology region (5’ homo) of about 1kb into 
CTD-S2S and CTD-S2A containing pGEX vectors already available in the lab, using restriction 
and ligation (Figure 21A). The homology arm was amplified using GoTaq PCR with primers 
containing restriction sites for PvuII and EcoRI at their 5’ ends. The two pGEX were cut by 
MlsI (MlsI and PvuII generate blunt extremities allowing the ligation of their product) and 
EcoRI allowing the incorporation of the 5’ homology fragment in the plasmid.  
The cloning of the two additional fragments needed, namely the SEC and the 3’ CTD 
homology arm (3’ homo) was performed by a Gibson Assembly strategy (Figure S2) that allows 
the one-step ordered joining of multiple fragments (Figure 21B). We thus made the PCR 
reactions to amplify the SEC and the 3’ homology region with primers sharing overlapping 
sequences to the plasmid or between them to allow the Gibson Assembly, performed as 
described by the manufacturer (New England Biolabs). This way, the plasmid containing the 
5’ homology region, the CTD-S2A, the SEC and the 3’ homology region was obtained. 
However, we failed to obtain the sister plasmid harboring the CTD-S2S, which was done 
through regular cloning replacing the CTD-S2A sequence by the CTD-S2S. 
After the verification of these three plasmids, we injected them in C. elegans with a plasmid 
coding for Cas9. Because the injection of plasmids can lead to the formation of 
extrachromosomal arrays that can be transmitted to the progeny and expressed, we co-injected 
mCherry fluorescent plasmids (myo-2::mCherry and myo-3::mCherry to mark the muscles and 
prab-3::mCherry to mark the nervous system) (Dickinson et al, 2015; FrØkjaer-Jensen et al, 
2008). These co-markers helped us to differentiate worms created by a proper genomic 
replacement event (roller, hygromycin resistant and not red when exposed to the appropriate 
wavelength) from worms carrying a combo of the plasmids as extrachromosomal arrays (roller, 
hygromycin resistant but also red) (Dickinson et al, 2015).  
Figure 21: Construction of the repair template to create a strain expressing either the CTD-S2S or CTD-S2A (mutated
CTD). (A). Integration of the 5’ homo in the pGEX using restriction and ligation. The 5’ CTD homology arm was amplified by
PCR using a set of primers containing restriction site in their 5’ part. This fragment was then cut by PvuII and EcoRI to allow the
ligation in the pGEX cut by MlsI and EcoRI . (B). Integration of the SEC (Dickinson et al, 2015) and the 3’ homo in the pGEX
already containing the 5’ homo and the mutated CTD. The two inserts were amplified by PCR with primers sharing homology with
the end of the CTD, cut with NotI (purple to insert the SEC), sharing homology between them (light blue to ligate the SEC with the
3’ homo) and sharing homology with the other side of the plasmid, cut with PfoI (red to insert the 3’ homo). After the PCR reaction,
a Gibson Assembly was performed following the protocol of New England Biolabs.
.
.
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After the injection sessions, either for the CTD-S2A or CTD-S2S, we never obtained roller, 
hygromycin resistant worms. A possible explanation is that the PAM present in the 5’ homology 
region in the repair template was not mutated due to the cloning strategy. Cas9 could thus cut 
the modified locus after repair as already discussed above. We thus performed an additional Q5 
site-directed mutagenesis on the repair plasmids to mutate the PAM in the 5’ homology region 
(Figure 22). We next injected the plasmid repair template containing the PAM mutation with 
the two plasmids coding for the sgRNAs and the one coding for Cas9 to first obtain the strain 
expressing the CTD-S2S. Indeed, we decided to try to generate this strain before the CTD-S2A 
because we knew that it is fully viable because we obtained it using our first strategy (two 
preassembled Cas9 ribonucleoproteins with a linear repair template). We injected 160 parental 
worms, however, we only obtained 21 roller, hygromycin resistant yet red worms suggesting 
that the plasmids formed extrachromosomal arrays and that the desired mutation was not 
incorporated in the genome. Indeed their progeny was not roller or hygromycin resistant due to 
the progressive loss of the extrachromosomal arrays.  
We, therefore, reasoned that pursuing the same strategy was counter-productive and 
consulted again the most recent literature. Indeed, it was reported than the direct injection of a 
preassembled Cas9 ribonucleoprotein (as in our first design) is more efficient to edit the genome 
than the use of plasmids. (Paix et al, 2015; Dickinson and Goldstein, 2016, Au et al, 2019). It 
was also reported that for insertions larger than 1 or 2kb (we want to insert a fragment of 
6500bp) or for insertions situated 30 nucleotides or more further than the Cas-9 mediated cut, 
plasmid repair templates with long homology arms are the most appropriate because they can 
accommodate large inserts (Paix et al, 2014; Dickinson and Goldstein, 2016; Paix et al, 2017). 
Consequently, to meet both arguments, we are currently trying to inject the two preassembled 
Cas9 RNPs along with the repair templates and the mCherry co-markers, therefore, combining 
the two strategies already tested. 
 
2.3. Characterization of the CTD-S2S strain  
The strain expressing the CTD-S2S was already obtained with the first strategy and 
available for further characterization.  
The objective is to check that the presence of silent mutations and the removal of introns 
from the DNA sequence coding for the CTD do not impact the expression of AMA-1, the CTD-
Ser2 phosphorylation, or do not result in phenotypes. To answer these questions, we first 
compared the brood size and the embryonic mortality between wild-type worms (expressing the 
genomic CTD) and worms expressing the CTD-S2S. Secondly, we compared the expression 
level of AMA-1 and its phosphorylation status between the two strains by Western blot and 
immunofluorescence.  
We assessed the brood size and embryonic mortality because it is a metric that characterizes 
the fitness of a strain and because most developmental abnormalities affect the fertility of an 
individual. Consequently, we counted the larvae and the unhatched (dead) embryos (Figure 
23A). No statistical difference was observed between the two strains. 
The expression level of AMA-1 and CTD-Ser2P in each strain was analyzed by Western 
blot using antibodies anti-CTD and anti-CTD-Ser2P (Figure 23B and C). In this analysis, 
AMA-1 with a non-phosphorylated CTD migrates faster than AMA-1 with a phosphorylated 
Figure 22: Q5 site-directed mutagenesis to mutate the PAM in the repair template to create a strain expressing either the
CTD-S2A or CTD-S2S. By using a forward primer containing the mutation of the PAM and a reverse primer annealing back-to
back to the forward primer, the entire plasmid is amplified by a PCR reaction and the desired mutation is introduced in the
plasmid.
.
.
.
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Figure 23: Characterization of the CTD-S2S mutant strain. (A).
Brood size (laid) and number of dead embryos (dead) between worms
expressing the genomic CTD or the CTD-S2S. No difference is
observed between the two strains. Error bars represent standard error.
Number of parental worms counted, n=7 (B). Western blot against
AMA-1 CTD using anti-CTD IgG (anti-CTD 8WG16 [Eurogentec
MMS-126P-050]). No difference in the expression of Pol II is observed
between the two strains. Anti-α-Tubulin IgG (Sigma-Aldrich T5168)
was used as a loading control. Size standards are indicated on the left.
Proteins are extracted using the sonicator protocol (see materials and
methods) (C). Western blot against CTD-Ser2P using anti CTD-Ser2P
IgG (anti-CTD-Ser2P 3E10 [Millipore 04-1571]). No difference is
observed between the two strains. (D). Immunofluorescence, with the
same antibodies as for the Western blot, analysing the expression of
AMA-1 and of CTD-Ser2P in the gonad arms of adult worms. There is
no difference between the two strains. DAPI marks the nuclei. DIC
stand for Differential Interference Contrast.
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CTD and that is why the non-phosphorylated CTD RNA polymerase appears lower on the gel. 
The higher band corresponds to the phosphorylated CTD polymerase and can migrate at 
different molecular weights depending on the CTD phosphorylation status (Greenleaf, 1992). 
Thus, it is not straightforward to analyze the CTD phosphorylation but figures 23B and C 
indicate that there is no obvious difference in the expression of AMA-1 or on CTD-Ser2P 
between the two strains.  
We also analyzed the expression level of AMA-1 and of CTD-Ser2P in each strain by 
immunofluorescence using the same antibodies as for the Western blot (Figure 23D). The 
experience was performed on adult worms, but because of their cuticle, the antibodies have 
difficulties to reach their target. The solution is to cut the worms in half allowing the gonad 
arms to come out of the cuticle. Consequently, we can only observe the worms’ gonad arms in 
this experiment. Figure 23D shows that there is no difference either on the expression of the 
polymerase or on the CTD-Ser2 phosphorylation between the non-mutated worms and the 
mutated one. 
In conclusion, the results of these experiments support that the silent mutations introduced 
into the DNA sequence coding for the CTD have no detectable impact.  
 
2.4. A technical control for the CRISPR-dependent gene targeting 
At the same time as performing injections to obtain a mutant strain expressing the CTD-
S2A or CTD-S2S, we injected a mix of plasmids to obtain a strain expressing the protein SLD-
3 tagged with an MNase and a 3-FLAG. Sld3 is a protein involved in the replication cycle. 
Indeed, it is the substrate of Cyclin-Dependent Kinases involved in the S phase of the cell cycle. 
After the phosphorylation of Sld3 by CDKs, Dpb11 can interact with it and the complex will 
promote the assembly of the replication fork helicase (Dhingra et al, 2015; Zegerman and 
Diffley, 2007). The MNase (Micrococcal Nuclease) is an endonuclease that can generate 
double-strand DNA breaks under high calcium concentration. It means that under physiological 
Ca2+ concentration, the fusion protein SLD-3-MNase will be recruited to the DNA with Dpb11 
and that the MNase will remain inactive. However, when genomic DNA will be exposed to 
high calcium concentration, the complex will be recruited to the DNA and the endonuclease 
will generate double-strand DNA breaks where SLD-3 is located. The cleaved chromatin can 
then be analyzed for example by a ligation-mediated PCR and sequencing. This technique 
allows for studying protein-chromatin interactions (Kubben et al, 2010).  
This mutant strain has no biological interest for us but has technical interest as it has already 
been obtained in the laboratory of a collaborator, Florian Steiner, in Geneva, using a mix of 
plasmids; a plasmid coding for Cas9, a plasmid containing a crRNA coupled with the tracrRNA, 
a plasmid repair template containing the SEC and the mCherry co-markers. Consequently, the 
goal of recreating this strain in our laboratory was to practice the use of the self-excising cassette 
and the mCherry co-markers as a screening strategy and to test the efficacy of the heat-shock.  
Florian Steiner sent us all the plasmids we needed to obtain the strain so we injected them 
into C. elegans. Briefly, the plasmid containing the crRNA coupled with the tracrRNA was also 
produced by cutting the pRB1017 plasmid by BsaI and by replacing the 20 random nucleotides 
before the tracrRNA by the nucleotides coding for the crRNA. This crRNA is designed to bind 
near the start codon of sld-3 (Figure 24) allowing the incorporation of the sequence coding for 
Figure 24: Construction of a strain expressing a tagged SLD-3. To obtain a strain expressing a tagged SLD-3, the
crRNA was designed to bring Cas9 near the start codon of sld-3. Cas9 thus induces a double-strand DNA break which is
repaired by homologous recombination with the plasmid repair template containing two homology arms to the genome,
the SEC and the desired tags (MNase and 3-FLAG).
Figure 25: Selection of mutant worms expressing SLD-3 tagged with a MNase and a 3-FLAG. After injection of parental worms,
we obtained one roller, hygromycin resistant and not red F1 worm meaning that the MNase with the SEC and the 3-FLAG was
incorporated into its genome. This worm was heterozygous for the incorporation of the desired modification as its progeny (F2)
contained non roller worms. By picking one roller F2 worm per plate, we obtained plates where 100% of the progeny (F3) were roller
meaning that they were homozygous for the expression of the MNase, the SEC and the 3-FLAG. These homozygous worms were
heat-shocked to induce the Cre recombinase. 50% of the heat-shocked worms were not anymore roller. However, 25% of not heat-
shocked worms were also not anymore roller.
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the MNase and the 3-FLAG in the genome (actually, in the Steiner lab, even if one is 
theoretically sufficient, they always use two plasmids coding for two crRNAs to optimize the 
targeting of the desired gene). The plasmid repair template is produced from the plasmid, 
described by Dickinson and co-workers, containing a fluorescent protein, a 3-FLAG, the SEC 
and ccdB fragments (Dickinson et al, 2015) by replacing the two ccdB fragments by homology 
arms to the genome and by replacing the fluorescent protein by the MNase but conserving the 
3-FLAG.  
After the injection sessions, we obtained a lot of roller and hygromycin resistants F1 worms 
due to the presence of the SEC. However, the majority expressed the red co-markers meaning 
that the injection had been correctly performed but that the plasmids were maintained as 
extrachromosomal arrays. The descendants of these F1 worms were no longer roller or 
hygromycin resistant because of the progressive loss of the extrachromosomal arrays. But we 
obtained one worm (1 to approximately 150 roller and hygromycin resistant worms) that was 
not red suggesting proper incorporation into the genome. Accordingly, the descendants of this 
worm were also roller and hygromycin resistant. We next isolated one roller per plate and 
screened for plates where 100% of the progeny were roller meaning that they were homozygous 
for the insertion (Figure 25). We performed a heat-shock on these homozygous worms to induce 
the Cre recombinase in order to remove the SEC. We did this by incubating 24 L1/L2 worms 3 
hours and 30 minutes at 34°C and then return them at 20°C until they become adults. 62.5% of 
the worms submitted to the heat-shock survived and among this 62.5 %, 50% were not roller 
anymore. As a control, we incubated 24 L1/L2 worms only at 20°C, they all survived but 
surprisingly, 25% were not roller anymore. We next noticed that the roller phenotype 
disappeared in approximately 20% of the progeny of a roller worm supposed to be homozygous 
for the expression of the SEC. Consequently, we presumed that the SEC is able to excise itself 
spontaneously without heat-shocking. To check this hypothesis, we decided to perform three 
different PCR reactions (Figure 26A) using three different forward primers but the same reverse 
primer (number 3194).  
The first PCR (3191-3194) is expected to generate a band of 1448bp only if the worm 
expresses the 3-FLAG (and thus most likely the MNase.) The second PCR (3192-3194) is 
expected to generate a 1643bp band if the worm is wild-type, a 2264bp band if the worm 
expresses the MNase and the 3-FLAG without the SEC and no PCR product if the worm 
expresses the MNase, the SEC and the 3-FLAG because the fragment is too long to be amplified 
by this reaction. The third PCR (3141-3194) is expected to generate a 2062bp band if the worm 
expresses the SEC. As the three forward primers are able to hybridize within the repair template, 
we needed to distinguish a PCR product corresponding to the integration into the genome from 
an extrachromosomal array, and the reverse primer was therefore designed in sld-3 downstream 
of the targeted homology region present in the repair template. We first performed these 
reactions on a wild-type worm as a control (Figure 26B). The first PCR gives no PCR products, 
the second shows a 1643bp but the third gives aspecific bands. We next performed these PCR 
on worms potentially homozygous for the expression of SLD-3-MNase-3-FLAG and which are 
roller and hygromycin resistant (Figure 26B). The first PCR gives a 1448bp band meaning that 
the 3-FLAG and the MNase are expressed, the third PCR gives the same aspecific bands than 
in the control but also gives a 2062bp band meaning that the worms express the SEC. However, 
if these worms were homozygous for the expression of the MNase, the SEC and the 3-FLAG, 
the second PCR would not have given a product. However, we obtained a 2264bp.  
..
Figure 26: PCR reactions to analyse the expression of the MNase, the SEC and the 3-FLAG in worms supposed to be
homozygous for their expression. (A). Cartoon of the three possible alleles that can be expressed by a worm with the length of
the PCR product given by three different PCR reactions, using the same reverse primer (number 3194), hybridizing in sld-3. The
first PCR uses the primer number 3191, hybridizing in the 3-FLAG, the second PCR uses the primer 3192, hybridizing in 5’
UTR of sld-3 and the third PCR uses the primer 3141, hybridizing in the SEC. (B). Agarose gel stained with ethidium bromide
indeed shows that on a wild-type worm, the PCR1 gives nothing, the PCR2 gives a 1643bp band but the third PCR gives
aspecific bands (꙳). On a worm supposed to be homozygous for the expression of the SEC, the MNase and the 3-FLAG and that
are roller and hygromycin resistant (Roller), the PCRs indicated that they are actually homozygous for the expression of the
MNase and the 3-FLAG but they express the SEC only on one of the two alleles. On a worm that has lost the roller and
hygromycin resistant phenotype (Not-roller), the PCRs indicated that they are homozygous for the expression of the MNase and
the 3-FLAG but they do not more express the SEC. The second single worm PCR protocol (see material and methods) was used.
Figure 27: The MAP tag. The MAP tag is composed of the fluorescent protein mVenus with a His8-tag, a 
Streptavidin Binding Peptide (SBP) and a FLAG tag inserted between β8-β9 of mVenus (Ma et al, 2012; 
Ma et al, 2014).
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Taken together, these results suggest that the tested roller worms are actually homozygous 
for the expression of the MNase and of the 3-FLAG but heterozygous for the expression of the 
SEC, which supports that the cassette has spontaneously excised due to the leakiness of the 
heat-shock promoter. We also performed these PCR reactions on worms supposed to be 
homozygous for the expression of the tagged SLD-3 but which have lost the roller phenotype 
without heat-shocking (Figure 26B). These worms express the 3-FLAG and thus most likely 
the MNase because the first PCR gives a 1448bp band and that the second gives a 2264bp band 
but they do not express the SEC because the third PCR did not give the 2062bp band 
corresponding to the expression of the cassette. This also confirms the hypothesis that the SEC 
is able to excise without heat-shock at 34°C, which was confirmed by Florian Steiner (personal 
communication).  
These results suggest that despite the self-excision of the cassette without heat-shocking, 
the SEC accompanied by the co-markers (mCherry plasmids) is an appropriate way to screen 
for potential mutant worms. Indeed the only roller, hygromycin resistant and negative for red 
fluorescence worm we obtained was properly mutated at the sld-3 locus. We, therefore, should 
be able to obtain the CTD-S2A or CTD-S2S strains by using this screening method and by 
screening roller, hygromycin resistant and red fluorescence negative F1 worms after injection 
sessions.  
3. Study of the regulation of CDK-12 
3.1. Construction of a strain expressing a tagged CDK-12  
To study how CDK-12 is regulated in vivo, we want to tag the kinase in order to identify 
putative physical partners and to study its phosphorylation status. To generate this strain, we 
first decided to use a tag that allows specific isolation of the target protein with the minimum 
contaminants to avoid false-positive. We first thought about using the TAP-tag (Li, 2010). 
However, the disadvantage of the TAP-tag is the presence of a calmodulin-binding peptide 
because of the existence of calmodulin-binding proteins in C. elegans (Shen et al, 2008). These 
could also bind to the calmodulin resin during the purification of the desired complexes and 
thus give false-positive results (Li, 2010). We thus looked for a derivative of the TAP-tag 
retaining its advantages in the absence of a calmodulin-binding peptide. Several options are 
available and we chose to use the MAP (Multifunctional tandem Affinity Purification) tag (Ma 
et al, 2012) because firstly, the purification of the target complex is reported to be very efficient, 
secondly, this tag works for the isolation of proteins in C. elegans and thirdly, this tag offers 
the possibility to study the localization of a protein thanks to the presence of a fluorescent 
protein (Ma et al, 2012). Indeed, the MAP tag is composed the mVenus with a His8-Tag, a 
Streptavidin-Binding Peptide (SBP) and a FLAG tag inserted into the surface loop between the 
beta barrels β8-β9 (Figure 27) (Ma et al, 2012).  
To incorporate the MAP tag, we designed a crRNA targeting the end of the cdk-12 ORF in 
order to fuse the tag to the C-terminal end of the kinase (Figure 28A). We used the IDT 
software. We could either chose a crRNA binding in the coding sequence of cdk-12, just before 
the stop codon, or in the 3’ UTR of cdk-12, just after the stop codon. We chose to work with 
the first proposition using a crRNA with an on-target score of 58 and an off-target score of 97 
(Figure 28B) because the crRNAs hybridizing in the 3’ UTR have bad specificity (off-target 
score of 0). 
..
Figure 28: Construction of a strain expressing CDK-12 tagged with the MAP tag. (A). A crRNA was designed to bring Cas9
near the stop codon of cdk-12. A double-strand break is thus generated to open the DNA and allows the homologous recombination
with the injected DNA in order to incorporate the MAP tag. (B). The crRNA is designed to bind just before the stop codon of cdk-12
to put the tag in the C-terminal part of the protein. (C). The MAP tag is flanked by homology regions to the break but silent
mutations (red) are inserted in one homology arm (the one that recognizes the crRNA) to prevent the crRNA from binding and thus
Cas9 to cut the modified genome.
.
. . .
Figure 29: CDK-12-MAP tag screening. (A). An agarose gel stained with ethidium bromide shows a possible mutant worm (lane 2)
that had the 541bp band, and a non-mutant worm (lane 1) with no PCR product. The lane “-“ is a F1 worm from a non-injected parental
worm as negative control. The first single worm PCR (see material and methods) was used (B). The agarose gel shows a possible
mutant worm (lane 1a and 1b) that had the expected 541bp band with the first designed set of primers (lane 1a) and the expected 727bp
band with the second designed set of primers (lane 1b) despite the presence of aspecific bands. Lane 2 is the negative control. (C).
Western blot against the FLAG using anti-FLAG IgG (Sigma-Aldrich F3165). No roller worms (tested roller) showed a band for the
expression of CDK-12 tagged with the MAP tag (108,6kDa). The negative control is an S. pombe strain which does not express the
FLAG tag. The positive control is an S. pombe strain expressing Rpb3-FLAG (35kDa). Size standards are indicated on the left. Proteins
were extracted using the NaOH extraction (see material and methods). (D). Ponceau staining served as a control to see if there were
proteins on the membrane. The lane “-“ is the negative control, the lane “+” is the positive control and the lane “T” is the tested roller.
(E). Exposition of roller worms to 515nm (excitation wavelength of the mVenus). No roller worms expressed the mVenus because what
we can see on the figure is the autofluorescence of the intestine. The way to check that the observed fluorescence was indeed due to the
intestine is to exposed worms to 358nm (excitation wavelength of the DAPI). In addition, the pharynx, gonad or head do not appear
fluorescent when exposed to 515nm. DIC stand for Differential Interference Contrast.
. .
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 The repair template containing the MAP tag flanked by homology arms to the C. elegans 
genome was made following Dokshin and co-workers protocol (Dokshin et al, 2018); by two 
different PCR reactions from a plasmid expressing the MAP tag (bought from Addgene). The 
first PCR was made using primers with no homology arms to C. elegans genome (short primers) 
and the second using primers with 120bp homology arms (long primers). The two PCR products 
were melted and reannealed to generate single-stranded overhangs repair template. This 
template should allow the homologous recombination with the genome to incorporate the MAP 
tag. In addition, we introduced silent mutations in the forward long primers used to amplify the 
MAP tag to prevent Cas9 from cutting the genome after it has been modified (Figure 28C).  
We injected a preassembled Cas9 RNP  (the protein Cas9 with the crRNA and the tracrRNA 
in vitro synthesized) and the linear repair template into the gonad arm of C. elegans to obtain a 
mutant worm (Figure 28A). To screen for potential mutants, we used the co-CRISPR technique 
with the co-injection marker, dpy-10 (cn64) to generate roller worms. We obtained roller worms 
that we screened by single worm PCR to check for the incorporation of the tag into the genome 
thanks to one of the two primers binding in the tag. Theoretically, the PCR screening strategy 
should generate a 541bp PCR product only if the worms were at least heterozygous. We 
obtained worms with this 541bp (Figure 29A) so we sequenced this PCR product but it 
surprisingly did not correspond to the MAP tag (Figure S3). It means that the set of primers we 
used can amplify a sequence of 500bp somewhere else into the genome. This is unexpected as 
we looked for off-target binding of the primers by blasting them against the entire C. elegans 
genome. To avoid sequencing all false-positive 541bp bands, we designed another primer that 
should give a 727bp PCR product if the worms are mutant. We obtained roller worms showing 
this 727bp (Figure 29B) band but with some aspecific bands also present in the negative control 
worm (not injected). We unsuccessfully tried to improve our PCR protocol in order to avoid 
these aspecific bands. We thus decided to use another method to check if the roller worms 
expressed the MAP tag. We performed Western blots on roller worms using an antibody anti-
FLAG and analyzed the roller worms under a fluorescent microscope to check if they expressed 
the mVenus. The results were negative in both experiments. Indeed on Western blots, using an 
S. pombe strain expressing a FLAG-tagged protein as a positive control, no roller worms 
expressed the FLAG tag (Figure 29C) (to be sure that there are proteins on the membrane, a 
ponceau staining was performed (Figure 29D)). In addition, no roller worms expressed the 
mVenus when exposed to the proper wavelength (515nm) (Figure 29E). Indeed, what we can 
observe in figure 29E is the intestine because it contains autofluorescent “lipofuscin granules” 
(Clokey and Jacobson, 1986). A way to check that indeed, the observed fluorescence was due 
to the intestine autofluorescence, is to expose worms to 358nm, the excitation wavelength of 
the DAPI. As nuclei were not marked by DAPI, only the “lipofuscin granules” of the intestine 
appeared fluorescent at 358nm. As the two signals (the one obtained at 515nm and at 358nm) 
co-localise, the signal observed by exposing worms to 515nm is likely due to the intestine 
autofluorescence rather than the expression of the MAP tag. Moreover, the pharynx, gonad or 
head do not appear fluorescent when exposed to 515nm. In conclusion, the nonspecific PCR 
reaction, the Western blots and the observation of roller worms under the fluorescence 
microscope show that after the injection of C. elegans, we obtained a lot of roller worms but no 
transgenic lines expressing a MAP tag version of CDK-12. 
We consequently decided to change the method and to use a mix of plasmids with a circular 
repair template in order to use longer homology arms to the C. elegans genome and the SEC as 
a screening strategy. 
Figure 30: Construction of the repair template to obtain a strain expressing a CDK-12-YPet-3-FLAG. The 5’ homology arm was
synthesized de novo in order to incorporate silent mutations to prevent Cas9 from cutting a modified genome. It was then amplified by a
PCR reaction with primers containing overlapping sequence with the plasmid pDD283 (Dickinson et al, 2015). The 3’ homology arm was
directly amplified from the genome by a PCR reaction with primers also containing overlapping sequence with the plasmid. The vector will
then be cut by SpeI and AvrII to remove the ccdB fragments and a Gibson Assembly will be performed.
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For the plasmid expressing the crRNA, we again used the pRB1017 digested with BsaI to 
introduce the crRNA. Normally, one crRNA is sufficient because the genome has to be cut 
once. However, we decided to use two independent crRNAs (like Florian Steiner to obtain the 
strain expressing SLD-3-MNase-3-FLAG) to optimize the targeting of the gene of interest. We 
thus chose to work with a second crRNA hybridizing 3 nucleotides upstream of the first one 
(on-target score of 67 and off-target score of 96). We, therefore, constructed two plasmids each 
containing one crRNA coupled with the tracrRNA. 
Concerning the repair template, we decided to change the tag and to use a fluorescent 
protein with a 3-FLAG instead of the MAP tag in order to directly use the plasmid described 
by Dickinson and co-workers because their technique seems to be very powerful to generate 
tagged protein in C. elegans (Dickinson et al, 2015). In addition, a fluorescent protein is also 
present so comparing to the MAP tag, we keep the advantage of being able to study the 
localization of the protein. Finally, the FLAG is generally used for immunoprecipitations and 
seems to allow specific protein purification (Gerace and Moazed, 2015). We thus requested the 
plasmid pDD283 containing the SEC with the 3-FLAG and the YPet as fluorescent protein 
(Dickinson et al, 2015) and we are currently making a Gibson Assembly to replace the ccdB 
fragments by homology arms to the end of cdk-12 (Figure 30). The downstream homology arm 
(3’ homo) was produced by PCR from genomic DNA with primers sharing overlapping 
sequences to the plasmid to allow the Gibson Assembly. The upstream homology arm (5’ 
homo), was synthesized de novo by IDT (Integrated DNA Technologies). Indeed, we failed to 
amplify this fragment by PCR reaction. In addition, it must contain the silent mutations to 
preclude Cas9 from cutting the modified locus (Figure 28C). We thus resorted to de novo 
synthesis of the 5’ homo in order to directly incorporate these silent mutations in the fragment. 
The 5’ homo was then amplified by PCR with primers containing overlapping sequences to the 
plasmid pDD283. The plasmid will next be cut with AvrII and SpeI to remove the ccdB markers 
(Dickinson et al, 2015) and the Gibson Assembly will be performed following the protocol of 
New England Biolabs. The last step will be the transformation of E. coli with the product 
resulting from the Gibson Assembly. Normally, only clones expressing the desired construction 
can grow because bacteria where the transformed plasmid still contained one or two ccdB 
fragments (in case where the Gibson Assembly failed) will not be able to develop. Indeed the 
protein CcdB is a poison for E. coli (Loris et al, 1999).  
When we have all the plasmids, we plan to inject them in C. elegans to obtain a strain 
expressing a tagged CDK-12.  
 
 
 
 
 
 
  
30 
 
Discussion and perspectives 
1. The co-CRISPR technique generates false-positive results 
Performing CRISPR/Cas9 experiments on C. elegans requires screening for mutant worms. 
Several techniques can be used for this purpose such as the co-CRISPR strategy (Dickinson and 
Goldstein, 2016). This method consists of editing two loci during the same microinjection 
experience, the locus of interest and a marker locus that produces a visible phenotype when 
edited. Consequently, worms expressing the visible phenotype are normally more likely to 
contain the desired mutation than worms with a “wild-type” phenotype (Dickinson and 
Goldstein, 2016). In the lab, we were working with the dpy-10 locus generating a roller 
phenotype when edited (Arribere et al, 2014). However, in our hands, this technique generates 
a lot of false-positive results as we obtained roller worms that were not modified at the ama-1 
or cdk-12 loci. These false-positive results could be explained by the fact that two loci are not 
necessarily edited in the same way, for example, because the two crRNAs have different 
efficiency depending on their sequence. Indeed, a G-rich sequence upstream of the PAM 
containing no more than four T/U residues seems to be most active (Dickinson and Goldstein, 
2016; Mouridi et al, 2017; Xu et al, 2015; Wu et al, 2014). False-positive (or false-negative) 
worms could also be obtained because the two loci are not edited in the same nuclei (Mouridi 
et al, 2017). Consequently, the presence of roller worms is more an indicator that the injection 
was properly performed and targeted the germline and that Cas9 is active rather than a 100% 
efficient screening strategy for difficult genome modifications (Mouridi et al, 2017). It should 
be noted that the size of the CTD largely exceeds the size of the commonly inserted sequences. 
 
2. The self-excising cassette and the mCherry co-markers, a 
powerful technique to screen mutant worms  
As the co-CRISPR strategy generates many false-positive results, we decided to change our 
screening method to use the self-excising cassette (SEC) described by Dickinson and co-
workers (Dickinson et al, 2015) in a plasmid repair template. This SEC contains a hygromycin 
resistance gene, the dominant sqt-1(d) gene generating a roller phenotype and a heat-shock 
inducible Cre recombinase to excise the cassette once the transgenic strain is obtained. Plasmids 
injected in the gonad can form extrachromosomal arrays that can be transmitted to the progeny. 
In order to assess their formation, plasmids carrying genes encoding fluorescent proteins are 
co-injected. This allows us to distinguish worms created by a proper genomic replacement (they 
do not stably express the co-markers) from worms carrying the plasmids in extrachromosomal 
arrays (they express the fluorescent proteins). The injection of these co-markers is used by 
several laboratories and reported to be very effective (Dickinson et al, 2013; Frøkjaer-Jensen 
et al, 2010; Tzur et al, 2013). 
The advantage of this cassette is the decreasing of the rate of false-positive worms because, 
by contrast to the co-CRISPR where a second locus is edited, the entire cassette is integrated 
into the genome at the targeted locus. Another advantage of this cassette is the presence of two 
positive selectable markers, the antibiotic resistance and the roller phenotype. The antibiotic 
resistance allows the detection of rare edits because even if the desired mutation occurs at a 
very low level, viable transgenic worms can be detected among all the dead (Dickinson and 
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Goldstein, 2016). This is opposite to the co-CRISPR where if the mutation of interest is rare, a 
lot of rollers can nevertheless be obtained. The roller phenotype normally allows the easy 
detection of homozygous mutant worms. Indeed, contrary to a heterozygous worm, the progeny 
of a homozygous is normally 100% roller (Dickinson et al, 2015). However, we discovered that 
the SEC is able to spontaneously self-excise without heat-shocking in the progeny of a 
homozygous worm leading to worm expressing the desired mutation but no more the roller 
phenotype. This result first surprised us as Dickinson and co-workers (Dickinson et al, 2015) 
do not mention this possibility but further readings from Kostrouchová and co-workers 
(Kostrouchová et al, 2017) who also used this cassette, reported a spontaneous excision of the 
SEC. 
In this master thesis, we tried to use the SEC and the mCherry co-markers to generate two 
mutant strains, one expressing a mutated CTD and one expressing a tagged CDK-12. However, 
at the moment, we did not succeed in generating either of these two strains. Nevertheless, the 
use of the self-excising cassette with the mCherry co-markers seems to be a powerful method 
to identify mutant worms as the only hygromycin resistant, roller and fluorescence-negative 
worm we obtained was properly targeted at the sld-3 locus.  
 
3. Can we obtain our C. elegans mutant strains?  
3.1. Strain expressing a mutated CTD 
The inhibition of CDK-12 in the nematode C. elegans induces an L1 arrest and a decrease 
in the CTD-Ser2P level. Our current model to explain this data is that the CDK-12 dependent 
CTD-Ser2 phosphorylation is required for the efficient recruitment of the CstF/SL2 snRNP 
complex to genes in position 2 an over in operons. Consequently, the inhibition of CDK-12 
results in un-trans-spliced mRNAs that become the target of the exonuclease XRN-2 or similar 
enzymes. The encoded proteins that are mostly involved in postembryonic development are 
thus not produced to the level required to overcome the L1 developmental arrest.  
An important aspect of this project is to check that the phenotype induced by the inhibition 
of CDK-12 is indeed due to its action on the Pol II CTD and not to its role in translation (Choi 
et al, 2019; Coordes et al, 2015). We thus wanted to create a C. elegans strain expressing a 
CTD where the CTD-Ser2 are replaced by alanines (CTD-S2A) to analyze its phenotype. 
Because of the complexity of the sequence coding for the CTD, the sequence coding for the 
CTD-S2A had to be adapted (codon-optimized and removal of introns). Consequently, another 
sequence, the CTD-S2S, containing the same silent modifications than the CTD-S2A but with 
serines in position 2, was produced. This sequence was generated to study if these non-desired 
modifications have biological impacts. 
To create the two mutant strains, one expressing the CTD-S2A and one expressing the CTD-
S2S instead of the genomic CTD, we used the CRISPR/Cas9 method with currently no success. 
Therefore, we may wonder if they can be obtained or not. We think that they can be generated. 
Indeed, we already obtained a strain expressing the CTD-S2S using our first design (by 
injecting preassembled Cas9 RNPs and a linear repair template) despite the fact that only one 
transgenic strain was recovered. This strain is perfectly viable and shows no difference either 
at the level of the phenotype or at the expression of AMA-1 or CTD-Ser2P compared to wild-
type worms. We are also confident that the strain expressing a CTD-S2A can be obtainable. 
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Indeed, using our first design, we obtained worms expressing a deleted CTD and even if worms 
homozygous for the CTD deletion are non-viable (what is in agreement with other studies 
showing that the deletion of the CTD is lethal (Corden, 2013)), the heterozygous worms follow 
the normal life cycle. This indicates that only one intact copy of the CTD is sufficient to allow 
the postembryonic development and that the guide RNAs properly targeted Cas9 to cut the 
endogenous ama-1 locus. Consequently, there is a good probability that the CTD-S2A mutant 
can be obtained at least as a heterozygous. Moreover, CTD-S2A mutants had already been 
obtained in other organisms such as in yeast (Coudreuse et al, 2010) or human cells (Gu et al, 
2012) though the construct was not integrated at the locus in the last case. The yeast CTD-S2A 
mutant mimics the yeast CDK-12 (named Lsk1) deletion and is viable despite showing a mating 
defect. We, therefore, hypothesize that the worm CTD-S2A mutant will mimic the L1 arrest 
observed when CDK-12 is inhibited. 
 
3.2. Strain expressing a tagged CDK-12 
As the inhibition of CDK-12 in C. elegans mimics the L1 developmental arrest that follows 
hatching in the absence of food, we postulate that the kinase could be regulated by 
environmental signals and thus by the insulin-like IGF-1 pathway probably by the PI3K/Akt or 
Ras/MAPK. To test this hypothesis, we want to create a mutant strain expressing a tagged CDK-
12 in order to immunoprecipitate the kinase and analyze its phosphorylation status and partners. 
However, at the moment, we were unable to generate the strain. We think, yet, that a CDK-12 
tagged strain must be obtainable because, in 2013, Bowman and co-workers generated a CDK-
12-GFP strain by MosSCI (Bowman et al, 2013; Wormbase website). This strain is viable and 
the kinase is active suggesting that fusing a tag at the C-terminal domain of CDK-12 does not 
impact its expression or function. Moreover, in the lab, we already tried to create a strain 
expressing a GFP and FLAG-tagged version of CDK-12 using the bombardment technique. 
This technique consists of the bombardment of DNA-coated gold particles into the gonad of C. 
elegans. This leads to the random integration of a transgene into the genome (Schweinsberg 
and Grant, 2013). By using this method, worms expressing the GFP were obtained, meaning 
that the tagged kinase is able to express. However, the transgene was probably not integrated 
into the genome because the GFP signal disappeared within a few generations. This result 
suggests that a tagged version of CDK-12 can be expressed in C. elegans.  
 
4. Perspectives 
4.1. Biological perspectives  
4.1.1. Strain expressing the CTD-S2A 
As already mentioned, the goal of producing a C. elegans mutant strain expressing a CTD-
S2A is to check that the phenotype induced by the inhibition of CDK-12 is well due to its action 
on the Pol II CTD namely the phosphorylation of the CTD-Ser2. Consequently, we are hoping 
that the replacement of all CTD-Ser2 by a non-phosphorylable residue such as alanines, will 
recapitulate the inhibition of CDK-12 and induces an L1 arrest. This will strengthen our model 
where the inhibition of CDK-12 leads to a developmental arrest because, in the absence of 
CTD-Ser2P, the SL2 snRNP is not recruited to operons and thus the mRNAs from genes 
involved in worm development are not protected and degraded by an exonuclease.  
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If our model is correct, worms homozygous for CTD-S2A should represent 25% of the 
progeny of a heterozygous worm and should arrest development at the L1 stage. Consequently, 
we will not be able to analyze the effect of the expression of a Pol II with a CTD-S2A in the 
other stages of development. Therefore, we thought of creating another mutant strain by 
MosSCI relying on the fact that the endogenous AMA-1 is inhibited by the mushroom toxin α-
amanitin (Sanford et al, 1983). This mutant would express both endogenous alleles of ama-1 
and an additional mutated copy integrated by MosSCI, expressing a CTD-S2A with a second 
mutation conferring resistance to α-amanitin. This second mutation is, for example, a 
substitution of a guanine in adenine (ama-1(m118)) (Sanford et al, 1983; Bowman et al, 2011; 
Wormbase website). By incubating this mutant in the presence of α-amanitin, we should be able 
to inhibit the endogenous AMA-1 at any developmental stage. Consequently, at this chosen 
stage, the only active AMA-1 will be the α-amanitin resistant one expressing a CTD-S2A. This 
would allow us to study the impact of the non-phosphorylation of the CTD-Ser2 at all C. elegans 
developmental stages. 
 
4.1.2. Strain expressing a tagged CDK-12 
The goal of producing a tagged CDK-12 mutant strain is to study the phosphorylation 
pattern and the partners of the kinase. Indeed there is a likely possibility that CDK-12 is 
regulated by phosphorylation of its N-terminal domain because first, it is known that in C. 
elegans the nutrient availability is connected to metabolism by the insulin-like IGF-1 pathway 
and its downstream effector, the PI3K/Akt or Ras/MAPK. Second, because previous work in 
our lab showed that the S. pombe homolog of CDK-12 is regulated by MAPK-mediated 
phosphorylation of its N-terminal domain.  
Therefore, we are planning to purify a tagged version of CDK-12 from worms hatched in 
the presence or absence of food and to analyze it by mass spectrometry. If our hypothesis that 
CDK-12 is regulated by the phosphorylation of its N-terminal domain by MAPK is correct, we 
are hoping to find that in one condition, CDK-12 interacts with MAPK and has a 
phosphorylated N-terminal domain and that in the other condition, CDK-12 has a non-
phosphorylated N-terminal domain. This leads to the activation or not of the kinase and thus to 
postembryonic development or L1 arrest.  
 
4.2. Technical perspectives 
For the moment, we are trying to obtain the C. elegans mutant strains by using the self-
excising cassette on a plasmid repair template either with a plasmid coding for Cas9 and 
plasmids coding for the sgRNAs or with a preassembled Cas9 RNP.  
However, if this failed we could try to reuse a linear repair template because it is more 
efficient to allow homologous recombination with the genome than a plasmid repair template 
(Paix et al, 2014; Dickinson and Goldstein, 2016; Paix et al, 2017) and because it avoids the 
creation of extrachromosomal arrays. However as for insertions larger than 1 or 2kb (the self-
excising cassette makes 5594bp), linear templates are not advisable (Paix et al, 2014; Dickinson 
and Goldstein, 2016; Paix et al, 2017), we should use another screening strategy. We could use 
for example only the gene sqt-1(d) or only a gene conferring an antibiotic resistance which 
would be integrated into the repair template. This gene would be incorporated into the genome 
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with the desired modification thus limiting the creation of false-positive but will allow the use 
of a linear repair template by decreasing the length of the inserts. 
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Conclusion 
 
 In this master thesis, we investigated the function of the kinase CDK-12 in the 
development of the nematode C. elegans. In the lab, it was previously shown that the inhibition 
of CDK-12 induced a decrease in the CTD-Ser2P level and that this decrease is correlated with 
an L1 arrest and a strong decrease of the mRNAs corresponding to genes in position 2 and over 
within operons. In this work, we tried to continue the study of CDK-12 by confirming that the 
phenotype induced by its inhibition is due to its function of phosphorylating the CTD-Ser2 and 
by finding how it is regulated. To do this, we tried to generate C. elegans mutant strains 
expressing either a Pol II with a CTD-S2A or a tagged CDK-12. To generate these strains, we 
tried to use variations of the CRISPR/Cas9 method but currently failed to obtain any of our 
strains of interest even though a technical control strain was obtained, indicating that the method 
itself is efficient. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31: PCR reactions to analyse the expression of the CTD-S2A. (A). Cartoon of the two possible alleles that can be
expressed by a worm with the length of the PCR product given by four different PCR reactions. (B). Agarose gel stained with
ethidium bromide shows that the first PCR (3141-3057) gives too much aspecific bands on a wild-type (WT) worm to be tested on
potential mutant worms for the expression of the CTD-S2A . The second single worm PCR protocol (see material and methods) was
used. (C). The agarose gel shows that the second PCR (3056-3055) gives a 1141bp band when performed on a roller, hygromycin
resistant and not red worm (R) indicating the presence of the sequence encoding the CTD-S2A. The lane “-” is a wild-type worm as
negative control. (D). Confirmation that the PCR product generated by the second PCR corresponds to the sequence encoding the
CTD-S2A. The figure shows the sequence encoding two repeats of the heptapeptide corresponding to the CTD-S2A.
..
.
.
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Addendum 
 
From the injection of 86 worms in order to obtain a strain expressing the CTD-S2A by 
using two Cas9 RNPs, the plasmid repair template containing the SEC and the mCherry co-
markers, I obtained 5 roller, hygromycin resistant but mCherry-positive worms, meaning that 
the injected plasmids most likely formed extrachromosomal arrays. However, while the writing 
of this master thesis was nearly completed, I obtained one roller, hygromycin resistant worm 
that was mCherry-negative, suggesting that it possibly expresses the CTD-S2A. Its progeny 
was indeed also roller and resistant to the presence of the antibiotic. To check that they express 
the desired modification and the self-excising cassette, I performed PCR reactions on these 
roller worms (Figure 31A). The first PCR (Figure 31A) uses the forward primer 3141 
hybridizing in the cassette and a reverse primer (3057) hybridizing after the sequence encoding 
the CTD (in the region corresponding to the 3’ CTD homology arm used in the repair plasmid). 
This PCR should give a 863bp band only if the sequence encoding the SEC is present. However, 
when I performed this PCR on wild-type worms, it gives numerous aspecific bands (Figure 
31B) so I decided not to perform this PCR on potential mutant worms. The second PCR (Figure 
31A) uses a forward primer (3056) hybridizing before the sequence encoding the CTD (in the 
region corresponding to the 5’ CTD homology arm used in the repair plasmid) and a reverse 
primer hybridizing in the CTD-S2A (3055). This reverse primer is unable to bind in the 
sequence encoding the genomic CTD due to the silent mutations introduced in the mutated 
sequence by Eurofins Genomics. This second PCR should give a 1141bp band only if the 
sequence encoding the CTD-S2A is present. I thus performed this PCR on wild-type worms 
where indeed, no PCR product was obtained (Figure 31C) and on potential mutant worms where 
a 1141bp band was obtained (Figure 31C). I next sequenced this PCR product checking that it 
corresponds to the CTD-S2A (Figure 31D).  
However, as primers 3056 and 3055 bind within the long homology regions of the repair 
template (as they were designed early on when we used a much shorter homology region), the 
obtained 1141bp amplicon does not warrant that the integration occurred at the targeted locus 
and could still result from the presence of an extrachromosomal array even though this is 
unlikely because worms are mCherry-negative. Consequently, to check that the roller, 
hygromycin resistant and mCherry-negative worms express the CTD-S2A from the endogenous 
locus, I am planning to perform a third PCR reaction (Figure 31A) using a forward primer 
(3198) hybridizing upstream of the sequence used as the 5’ homology arm and a reverse primer 
(3199) hybridizing within the CTD-S2A. This PCR should give a 1320bp band only if the 
sequence encoding the CTD-S2A is incorporated at the ama-1 locus.  
I am also planning to perform a fourth PCR reaction (Figure 31A) using the forward 
primer 3056 and a reverse primer (3058) hybridizing in the first endogenous intron of the 
genomic CTD. This PCR will be performed to check if the obtained roller, hygromycin resistant 
and mCherry-negative worms are heterozygous or homozygous for the expression of the CTD-
S2A. I expect heterozygous worms as it is very unlikely that the CTD-S2A mutant can be 
propagated.  
 
  
37 
 
Material and methods  
 
Growth conditions and Strains 
C. elegans strains are derived from the Bristol N2 strain. In the lab, worms are cultured on petri 
plates or in liquid medium. On petri plates, they are maintained at 20°C on NGM-agar plates 
(Nematode Growth Media – agar: 51,3mM Nacl; 1mM CaCl2; 1mM MgSO4; 25mM KH2PO4; 
5µg/mL cholesterol and 1,25g peptone with 8,5g agar for 500mL)) seeded with E. coli OP50. 
In liquid medium, they are cultured on a shaker at 20°C in S-Basal (0,1M NaCl; 50mM 
KH2PO4; 3mM MgSO4; 4mM CaCl2; 1mM potassium citrate; 5µg/mL cholesterol) with E. coli 
HB101.  
Brood size analysis and Embryonic mortality  
On day 0, one L4 worm of each genotype is transferred to individual plates. On day 1, worms 
are adult and allow to lay eggs. On day 2, they are moved to another plate and on day 3, they 
are again removed. On day 4, the first plate is counted. On day 5, the second plate is counted 
and on day 6, the third one. On each counting day, larvae are counted as well as unhatched 
embryos. The sum of larvae plus unhatched embryos on all 3 plates of a single worm is its total 
brood size. The embryos unhatched after 48 hours are dead. The ratio of dead eggs to the total 
brood size is the embryonic mortality.   
Protein extraction using the sonicator 
Worms ( 18000 L4 in liquid culture) are pelleted, washed two times in M9 (42,2mM Na2HPO4; 
22mM KH2PO4; 85,7mM NaCl; 1mM MgSO4) and frozen. Thawed worms are resuspended in 
4X Laemmli Sample Buffer (200mM Tris pH8,5; 8% SDS; 40% glycerol), boiled for 5 minutes 
at 95°C, vortexed and then sonicated on a Diagenode Bioruptor Sonicator for 10 cycles (30 
seconds ON and 30 seconds OFF) to break the worms’ cuticle.  Next, the worms are spun and 
the supernatant (containing the soluble proteins) is collected. Protein concentration is 
determined by a Pierce assay and equal amounts of protein are loaded on Bio-Rad mini-
PROTEAN TGX gels 4-15%. This protocol is mainly used for quantitative analysis.  
Protein extraction using a NaOH extraction 
Worms from one nearly starved plate (with lots of adult worms) are collected in M9 + Triton 
0,01%. They are washed two times in M9 and one in demineralized water before being snap-
freezed. They are then exposed to 300µL of water with 300µL of NaOH 0,6M for 10 minutes 
at room temperature and next spun 3 minutes at 14000rpm. The supernatant is discarded and 
the pellet (containing the protein) is resuspended in loading buffer (60mM Tris-HCl pH6,8; 4% 
β-mercaptoethanol; 4% SDS; 0,01% Bromophenol blue; 5% glycerol), incubated 10 minutes at 
70°C and spun. The supernatant is finally collected and directly loaded on a Bio-Rad mini-
PROTEAN TGX gels 4-15%. This protocol is used for qualitative analysis but not quantitative 
because protein concentration can not be determined. Indeed the basic pH of the NaOH 
interferes with the Pierce assay.  
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Western blot  
Proteins are loaded on a Bio-Rad mini-PROTEAN TGX gel 4-15% and run for 45 minutes at 
150V. Proteins are next transferred to a nitrocellulose membrane using the Bio-Rad Trans-Blot 
Turbo Transfer System (settle on High Molecular Weight 1,3A – 25V – 10 minutes or Mixed 
Molecular Weight 1,3A – 25 – 7 minutes). The membrane is blocked with Skin Milk Powder 
(5%) (Sigma-Aldrich) and exposed to primary antibodies overnight at 4°C (anti-α-Tubulin 
1/1000 [Sigma-Aldrich T5168]; anti-CTD 8WG16 1/1000 [Eurogentec MMS-126P-050]; anti-
CTD-Ser2P 3E10 1/1000 [Millipore 04-1571]; anti-FLAG 1/1000 [Sigma-Aldrich F3165]). 
After that, the membrane is washed 3 times in PBS-Tween (0,05%) and then exposed to 
secondary antibody (anti-mouse IgG Perox 1/5000 [GE NA931]; anti-rat IgG Perox 1/5000 
[Dako P0450]). Finally, the membrane is washed two times with PBS-Tween (0,05%), one last 
time with PBS and revealed by PerkinElmer Western Lightning Plus-ECL on an ImageQuant 
LAS 4000 machine. 
Ponceau staining 
After the revelation, the membrane is washed with demineralized water and incubated in 
Ponceau solution (0,1% Ponceau S (Sigma-Aldrich P3504), 5% acetic acid) for 3 minutes. The 
membrane is then washed with water and finally photographed. 
Immunofluorescence 
Worms are killed in NaN3 (50mM) on poly-lysine coated slides and cut in half with a 22G 
needle (BD Microlance 3). They are next frozen between slide and coverslip, for at least one 
hour, at -80°C on a metal plate, before being freeze-cracked by flipping the coverslip from the 
slide. The slides are then fixed using MetOH 100% (20 minutes at room temperature) and a 
3,7% formaldehyde solution (30 minutes at room temperature) (10mL of Formaldehyde 
solution 37% [Sigma-Aldrich 252549] in 30 mL of PBS). They are then washed twice with 
PBS, once with PBS-tween (0,05%) and incubated with primary antibodies in wet chambers 
overnight at 4°C (anti-CTD 8WG16 1/2000 [Eurogentec MMS-126P-050]; anti-CTD-Ser2P 
3E10 1/2000 [Millipore 04-1571]). The next day, the slides are washed three times with PBS-
Tween (0,05%) and incubated with secondary antibodies one hour at room temperature in wet 
chambers (anti-rat IgG Alexa488 1/2000 [Invitrogen A21208]; anti-mouse IgG Alexa594 
1/2000 [Invitrogen A11005]). Finally, the slides are washed twice with PBS-Tween (0,05%), 
once with PBS and mounted using Fluoroshield (containing DAPI) (Sigma-Aldrich F6057). 
Slides are observed on a Zeiss Axio Imager Z1 microscope with a Hamamatsu Digital Camera 
C11440 using the Zeiss software ZEN. The time of the exposition was 3 seconds for Alexa488, 
1 second for Alexa594 and 5 milliseconds for DAPI. 
Single worm PCR, first protocol 
Prior to PCR, worms are digested with proteinase K (0,2mg/mL final) (Roche Diagnostics 03 
115 828 001) in 1X Colorless GoTaq Reaction Buffer (Promega M792A), for 1 hour at 65°C 
to obtain a worm lysate. The proteinase K is inactivated 15 minutes at 95°C before the worm 
lysate containing DNA is used for PCR.  
The PCR reaction is performed using GoTaq polymerase (GoTaq G2 DNA Polymerase, 
Promega M748B) with 3µL of worm lysate from proteinase K treated worms, 5µL of 5X Green  
GoTaq Reaction Buffer (Promega M791A), 2µL of primers at 10µM, 0,25µL of dNTP at 
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20mM, 0,125µL of GoTaq polymerase and 12,7µL of water. The annealing temperature 
corresponds to the Tm (Primer Melting Temperature) of the primer with the lowest Tm less 2 
and the extension time is 1 minute per kb. 
Single worm PCR, second protocol  
Prior to PCR, worms are digested with proteinase K (1mg/mL final) (Roche Diagnostics 03 115 
828 001) in 1X Colorless GoTaq Reaction Buffer (Promega M792A), first by snap-freezing for 
15 minutes and then by incubating 1 hour at 65°C to obtain a worm lysate. The proteinase K is 
inactivated 15 minutes at 95°C before the worm lysate containing DNA is used for PCR. 
The PCR reaction is performed using GoTaq polymerase (GoTaq G2 DNA Polymerase, 
Promega M748B) with 1,5µL of worm lysate from proteinase K treated worms, 5µL of 5X 
Green GoTaq Reaction Buffer (Promega M791A), 2µL of primers at 10µM, 0,25µL of dNTP 
at 20mM, 0,125µL of GoTaq polymerase and 14,1µL of water. The annealing temperature 
corresponds to the Tm (Primer Melting Temperature) of the primer with the highest Tm plus 1,3 
and the extension time is 1 minute per kb. 
PCR 
The PCRs to generate the linear repair templates for the CTD-S2A or CTD-S2S were performed 
using Expand polymerase (Expand High Fidelity PCR System, Roche Diagnostics 
11732650001) on the plasmids created by Eurofins Genomics. 
The PCRs for the amplification of the “MAP tag” were performed using GoTaq polymerase 
(GoTaq G2 DNA Polymerase, Promega M748B) on the plasmid pcDNA4 (order on Addgene). 
The PCR for the amplification of the “5’ CTD homology arm” was performed using GoTaq 
polymerase (GoTaq G2 DNA Polymerase, Promega M748B) on worm lysate. The PCR for the 
amplification of the Self-Excising Cassette (SEC) and the “3’ CTD homology arm” were 
performed using Q5 polymerase (Q5 High-Fidelity DNA polymerase, New England Biolabs 
M0491S) on the plasmid pDD283 and on commercial C. elegans genomic DNA (Zyagen GC-
280) respectively.  
The PCRs to amplify the “5’ homology arm” and “3’ homology arm” to generate the plasmid 
repair template to obtain a tagged CDK-12 were made using Q5 polymerase (Q5 High-Fidelity 
DNA polymerase, New England Biolabs M0491S) on the gBlocks synthesized by IDT and 
commercial C. elegans genomic DNA (Zyagen GC-280) respectively. 
The protocol provided by the manufacturer was followed for each enzyme. 
Restriction reaction 
The restrictions reactions were performed using the ThermoFisher Scientific FastDigest 
enzymes, BsaI (FD0293), PvuII (FD0634), MlsI (FD1214), EcoRI (FD0274), NotI (FD0593), 
PfoI (FD1754), SpeI (FD1254) and AvrII (FD1564) following the protocol provided by the 
manufacturer for each enzyme. 
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Ligation of the “5’ CTD homology arm” in the pGEX 
The “5’ CTD homology arm” amplified by PCR was ligated into the cut-pGEX using the T4 
DNA ligase (New England BioLabs M0202) following the protocol of the manufacturer. 20µL 
of ligation products is next added to 50µL of competent cells (E. coli DH10B). The competent 
cells are left 10 minutes on ice, heat-shocked one minute at 42°C and directly returned to ice 
for 5 minutes. 950µL of LB Broth Base (Lennox L Broth Base, Invitrogen 12780-029) is added 
and bacteria are incubated 1 hour at 37°C, 300rpm. Then, bacteria are pelleted, 900µL of 
supernatant is removed and the cells are resuspended in the remaining volume of LB. This 
volume is finally spread onto an LB-amp-agar plate (Lennox L Agar, Invitrogen 22700-041; 
Ampicillin sodium salt, Sigma-Aldrich A9518-25G). 
Gibson Assembly 
The Gibson Assembly reactions were performed using the Gibson Assembly Cloning Kit of 
New England Biolabs (E5510S) following their protocols (Gibson Assembly Protocol (E5510) 
and Gibson Assembly Chemical Transformation Protocol (E2611)). The primers were designed 
with NEBuilder Assembly Tool.  
Q5 Site-Directed Mutagenesis 
The Q5 Site-Directed mutagenesis was made using the Q5 Site-Directed Mutagenesis Kit of 
New England Biolabs (E0554S) following their protocol (Q5 Site-Directed Mutagenesis Kit 
Quick Protocol (E0554)). The primers were designed with NEBaseChanger.  
crRNA cloning in the pRB1017 plasmid 
2µg of each oligonucleotide is resuspended in 50µL of annealing buffer (10mM Tris pH7,5; 
50mM NaCl; 1mM EDTA). They are annealed by heating 5 minutes at 95°C. After allowing to 
come back to room temperature, annealed oligos are diluted into nuclease-free water to obtain 
a final concentration of 8ng/µL. These annealed diluted oligonucleotides are ligated into the 
BsaI-cut pRB1017 vector using the T4 DNA ligase (Promega, M180A) by incubating 50ng of 
BsaI-cut plasmid, 8ng of annealed diluted oligonucleotides, 1µL of Ligase 10X Buffer, 1µL of 
T4 DNA ligase and nuclease-free water for 3 hours at room temperature. The last step is the 
transformation of competent cells (E. coli DH10B) with 10µL of ligation product. The 
competent cells are left 10 minutes on ice, heat-shocked one minute at 42°C and directly 
returned to ice for 5 minutes. 950µL of LB Broth Base (Lennox L Broth Base, Invitrogen 
12780-029) is added and bacteria are incubated 1 hour at 37°C, 300rpm. Then, bacteria are 
pelleted, 900µL of supernatant is removed and the cells are resuspended in the remaining 
volume of LB. This volume is finally spread onto an LB-kan-agar plate (Lennox L Agar, 
Invitrogen 22700-041; Kanamycin Monosulphate, Formedium KAN0005). 
Miniprep 
Minipreps are made with the Sigma-Aldrich GenElute Plasmid Miniprep Kit (PLN350-1KT) 
following the protocol provided by the manufacturer. 
Midiprep 
Midipreps are made with the Macherey-Nagel NucleoBond Xtra Midi Kit (740410) following 
the manufacturer protocol. 
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Sanger Sequencing 
All Sanger sequencings are sent to Eurofins Genomics (Mix2Seq Kit). 
CRISPR mix preparation 
Preparation of the injection mix with a preassembled Cas9 ribonucleoprotein and the linear 
repair template is made as previously described (Dokshin et al, 2018). Briefly, the protein Cas9 
(5µg), the tracrRNA (2µg), the crRNA against Dpy-10 (0,56µg) and the crRNAs against the 
gene of interest (0,56µg of each) are incubated 10 minutes at 37°C to allow the formation of 
the Cas9 ribonucleoprotein. At the same time, 2µg of the linear repair template without 
homology arm (generated by PCR with the short primers), with 2µg of the linear repair template 
with homology arms (generated by PCR with the long primers) are heated to 95°C and cooled 
to 4°C to allow the melting and reannealing of the two PCR products. Finally, the repair 
template mixture is added to the Cas9 ribonucleoprotein with 2,2µg of the repair template for 
Dpy-10 (cn64) and water to obtain a final volume of 20µL. To avoid needle clogging, the 
CRISPR mix is spun at 14000 rpm for 2 minutes and about 17µL is transferred to a fresh tube. 
Preparation of the injection mix using a mix of plasmids is made by adding in the same tube, 
the plasmid coding for Cas9 (50ng/µL final), the two plasmids coding for the crRNAs and 
tracrRNA (25ng/µL final), the plasmid repair template (100ng/µL final), the plasmid coding 
for prab-3::m-Cherry (10 ng/µL final), the plasmid coding for myo-3::m-Cherry (5ng/µL final), 
the plasmid coding for myo-2::m-Chery (2,5ng/µL final), and water to obtain a final volume of 
20µL. To avoid needle clogging, the mix is spun at 14000 rpm for 2 minutes and about 17µL 
is transferred to a fresh tube (protocol adapted from Dickinson et al, 2015). 
Preparation of the injection mix using a preassembled Cas9 RNP with the plasmid repair 
template is made by incubating 10 minutes at 37°C, the protein Cas9 (5µg), the tracrRNA (2µg), 
and the crRNAs against the gene of interest (0,56µg of each). The plasmid repair template 
(100ng/µL final), the plasmid coding for myo-3::m-Cherry (5ng/µL final), the plasmid coding 
for myo-2::m-Chery (2,5ng/µL final) and water to obtain a final volume of 20µL are then added. 
To avoid needle clogging, the mix is spun at 14000 rpm for 2 minutes and about 17µL is 
transferred to a fresh tube (protocol adapted from Au et al, 2019).  
Microinjection 
The day before the injection, L4 worms are picked onto a new NGM-agar plate. The objective 
is to obtain a synchronized population of young adults (containing about 10 embryos) to 
perform the injection (Kadandale et al, 2009). Indeed, L4 worms are difficult to inject as the 
gonad is not completely open and too old adult worms are also difficult to inject because they 
contain lots of eggs compressing the gonad and thus making it barely visible.  
15 minutes before the injection, the young adult worms are transferred to an NGM-agar plate 
without bacteria because the presence of bacteria onto the worm’s cuticle can clog the needle 
(Kadandale et al, 2009).  
To perform the injection, a young adult is transferred to a 2% agarose pad covered in halocarbon 
oil 700 (Sigma-Aldrich H8898) using an eyelash mounted on a tip. This worm is next attached 
to the pad by pushing it with the eyelash. This allows preventing the worm from moving during 
the injection. The pad is next placed under the microscope (Zeiss Axio Vert A1) and the needle 
(Eppendorf, FemtoTip2) is loaded with 2µL of the injection mix and mounted onto the 
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micromanipulator (Eppendorf, FemtoJet2 with Eppendorf TransferMan NK 2). The needle is 
then placed near the worm and injection is performed outside the worm to check the needle’s 
opening. If enough liquid is ejected, the worm can be injected but if no liquid is ejected, the 
needle has to be open. To open the needle, it is scraped against the agarose pad.  
To inject the worm, the needle is inserted into the gonad syncytium and injection is performed. 
A sign that the injection was correctly performed is the visualization of the swelling of the 
gonad. After the injection, the worm is transferred onto a new culture plate using the eyelash 
and washed with 10µL of M9. 
Selection of mutant worms using the self -excising cassette 
After the injection (on day 0), parental worms are allowed to lay eggs for 4 days. On day 4, 
250µL of hygromycin 10mg/mL (Hygromycin B from Streptomyces hygroscopicus, Sigma-
Aldrich, H9773) is added per plate. From day 4 to day 11, plates are checked to find roller and 
hygromycin resistant F1 worms. These potential mutant worms are isolated into new plates (one 
worm per plate) and checked for the expression of the red co-markers using the Modular Stereo 
Microscope for Fluorescent Imaging Leica MZ10 F with the Leica Filter set ET mCherry 
(10450098). Only the not red worms are kept because they probably express the desired 
mutation. The progeny (F2) of these F1 roller, hygromycin resistant and not red worms are also 
isolated and the homozygous plates (where the entire progeny (F3) is roller) are identified. 
These homozygous worms are heat-shocked by incubating L1/L2 worms for 3,5 hours at 34°C. 
After heat-shock, worms are returned to 20°C for 2-3 days until they become adults (protocol 
adapted from Dickinson et al, 2015).  
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Annexes  
1. Abbreviations 
 
°C celsius degree 
µg microgram 
µL microliter 
µM micromolar 
3’ homo 3’ homology region 
3’ss 3’ splice site 
5’ homo 5’ homology region 
5’ss 5’ splice site 
A ampere 
Akt Protein Kinase B (PKB) 
AMA-1 Amanitin-binding subunit of RNA polymerase II 
as analog-sensitive 
ATP Adenosine Tri-Phosphate  
bp base pair 
c-Abl Abl tyrosine kinase isoform C 
Cas9 CRISPR associated protein 9 
CDK Cyclin-Dependent Kinase 
ChIP Chromatin Immunoprecipitation 
CPSF Cleavage and Polyadenylation Specificity Factor 
CRISPR Clustered Regularly Interspaced Short Palindromic Repeats 
crRNA CRISPR RNA 
CstF Cleavage stimulatory Factor 
CTD carboxy-terminal domain  
CTD-S2A/CTD-S5A RNA polymerase II carboxy-terminal domain where the serines 
in position 2/5 are replaced by alanines 
CTD-S2S RNA polymerase II carboxy-terminal domain containing silent 
mutations but retaining serines in position 2 
CTD-Ser2/CTD-Ser5/CTD-Ser7 serine in position 2/5/7 of the RNA polymerase II carboxy-
terminal domain 
CTD-Ser2P/CTD-Ser5P/CTD-
Ser7P 
phosphorylated serine in position 2/5/7 of the RNA polymerase 
II carboxy-terminal domain 
CTD-Thr4 threonine in position 4 of the RNA polymerase II carboxy-
terminal domain 
CTD-Tyr1 tyrosine in position 1 of the RNA polymerase II carboxy-
terminal domain 
DAF-2 Abnormal Dauer Formation 2 
DAPI 4',6-diamidino-2-phénylindole 
DNA  deoxyribonucleic acid 
dNTP deoxynucleotide triphosphate 
Dpb11 DNA polymerase B (II) 
DSIF DRB-Sensitivity-Inducing-Factor 
dsRNA double-stranded RNA 
DTC distal tip cell 
Fcp1 CTD phosphatase FCP1 
G gauge 
g gram 
GFP Green Fluorescent Protein 
His8-tag polyhistidine tag 
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IGF-1 Insulin-Like Growth Factor-1 
ILP Insulin-Like Peptide 
kb kilobase 
Lsk1 Latrunculin Sensitive Kinase 1 
M molar 
MAP tag Multifunctional tandem Affinity Purification tag 
MAPK Mitogen-Activated Protein Kinase 
MceI mRNA-Capping Enzyme 
mg milligram 
mL milliliter 
mM millimolar 
MNase Micrococcal Nuclease 
MosSCI Mos1 mediated Single Copy Insertion  
MosTIC Mos1-excision Transgene-Instructed gene Conversion 
mRNA messenger RNA 
ncRNA non-coding RNA 
NELF Negative Transcription Elongation Factor 
ng nanogram 
NGM Nematode Growth Media 
nm nanometer 
Nrf2 Nuclear factor erythroid 2-Related Factor 2 
ORF Open Reading Frame 
PAM Protospacer-Adjacent-Motif 
PAS Polyadenylation Signal 
Pcf11 Pre-mRNA Cleavage complex II protein  
PCR Polymerase Chain Reaction 
PI3K Phosphoinositide 3-Kinase 
PIC Pre-Initiation Complex 
Pol  RNA polymerase  
pre-mRNA pre-messenger RNA 
P-TEFb Positive Transcription Elongation Factor b  
qRT-PCR quantitative Reverse Transcription-Polymerase Chain Reaction 
Rat1 Ribonucleic Acid-Trafficking protein 1 
RNA ribonucleic acid 
RNAi RNA interference 
RNAseq RNA sequencing 
RNP ribonucleoprotein 
RPAP2 RNA Polymerase II Associated Protein 2 
Rpb RNA Polymerase B 
rpm revolutions per minute 
SBP Streptavidin-Binding Peptide 
SEC self-excising cassette 
sgRNA single guide RNA  
SL spliced leader 
SL RNA splice leader RNA 
SLD-3 Synthetically Lethal with Dpb11-1 
snRNA  small nuclear RNA 
snRNP small nuclear ribonucleoprotein 
Ssu72 CTD phosphatase SSU72 
Ste11 Serine/Threonine-protein kinase STE11 
TAP-tag Tandem Affinity Purification tag 
TBP TATA Binding Protein 
TFIIB/TFIID/TFIIE/TFIIH/TFIIF transcription factor II B/D/E/F/H 
Tm Primer Melting Temperature  
TMG cap Trimethylguanosine cap 
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tracrRNA trans-activating CRISPR RNA 
UTR Untranslated Region 
V volt 
XRN2 5’-3’ exoribonuclease 2 
YPet Yellow Fluorescent Protein for energy transfer 
 
2. Supplemental information 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S1: Sequencing of the 500bp PCR product expressed by worms injected for the expression of the CTD-S2A. 
These worms express a deleted CTD. 
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Figure S2: Gibson Assembly. The Gibson Assembly allows to join several DNA 
fragments (A and B) using overlapping regions. From these overlapping regions, an 
exonuclease will digest the 5’ extremities to create single-strand 3’ overhangs. These 3’ 
free extremities can then anneal, and a polymerase will extend them using the other 
fragment as a template. Finally, a ligase will seal the nicks. All fragments that possess 
overlapping regions will thus be assemble (A+B) (adapted from New England Biolabs 
website). 
 
Figure S3: Sequencing of a potential CDK-12 tagged mutant strain. Worms with a 541bp PCR product potentially express a 
tagged CDK-12. This PCR product was sequenced to see if it corresponded to CDK-12 with the incorporation of the MAP tag but 
it didn’t. It means that theses worms are not mutants.  
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Usage 5’-sequence- 3’ Forward/Reverse 
crRNA targeting the beginning of the 
CTD  
CAAUGAAGGAGGAUGGUCUC  / 
crRNA targeting the end of the CTD  UAUGAAUUUGGAUCAUAAGU  / 
Short primer to amplify the CTD-S2S 
from the plasmid produced by 
Eurofins Genomics  
CTGGGTGCGTTATCCCCACG  Forward 
Short primer to amplify the CTD-S2S 
from the plasmid produced by 
Eurofins Genomics  
TTATGAGTTAGGATCATAGGTCGG  Reverse 
Long primer to amplify the CTD-S2S 
from the plasmid produced by 
Eurofins Genomics  
GTGGAACTCTGGAGTCACACCGACGTATGCTGG
AGCCGCCTGGTCGCCTACCACAGGTGGAATGTC
GCCTGGTGCTGGATTTTCACCGGCTGGAAATAC
GGATGGAGGAGCATCGCCGTTCAATGAAGGAG
GATGGTCTCCtGCATCGCCTGGGGATCCA-
CTGGGTGCGTTATCCCCACG 
Forward 
Long primer to amplify the CTD-S2S 
from the plasmid produced by 
Eurofins Genomics  
AATTAGAGGAGGAAAAAATTTTGAAAAATTAA
AAGAAAAATAAATAAATAATGCTCAACATTTTT
TTGGGGTAAAATAGATAGAAATCGGCGAAAAT
TGCCCAAAAAAACGGGAAAAATC-
TTATGAGTTAGGATCATAGGTCGG 
Reverse 
Short primer to amplify the CTD-S2A 
from the plasmid produced by 
Eurofins Genomics  
TTAGGTGCCCTGAGTCCTCG Forward 
Short primer to amplify the CTD-S2A 
from the plasmid produced by 
Eurofins Genomics  
TTAACTGTTCGGATCGTACGTC Reverse 
Long primer to amplify the CTD-S2A 
from the plasmid produced by 
Eurofins Genomics  
GTGGAACTCTGGAGTCACACCGACGTATGCTGG
AGCCGCCTGGTCGCCTACCACAGGTGGAATGTC
GCCTGGTGCTGGATTTTCACCGGCTGGAAATAC
GGATGGAGGAGCATCGCCGTTCAATGAAGGAG
GATGGTCTCCTGCATCGCCTGGGGATCCA-
TTAGGTGCCCTGAGTCCTCG 
Forward 
Table S1: Lists of primers used in this master thesis  
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Long primer to amplify the CTD-S2A 
from the plasmid produced by 
Eurofins Genomics  
AATTAGAGGAGGAAAAAATTTTGAAAAATTAA
AAGAAAAATAAATAAATAATGCTCAACATTTTT
TTGGGGTAAAATAGATAGAAATCGGCGAAAAT
TGCCCAAAAAAACGGGAAAAATC-
TTAACTGTTCGGATCGTACGTC 
Reverse 
Primer to screen for the expression of 
the mutated CTD 
GCAGAATGTTGTAATGGGCG Forward 
Primer to screen for the expression of 
the mutated CTD 
TGGCTCATGCTCACGCTCTG Reverse 
Primer used to sequence the PCR 
product corresponding to a deleted 
CTD 
GCAGAATGTTGTAATGGGCG Forward 
Oligonucleotide coding for the crRNA 
targeting the beginning of the CTD 
and integrated in the pRB1017 plasmid  
TCTTGCAATGAAGGAGGATGGTCTC Forward 
Oligonucleotide coding for the crRNA 
targeting the beginning of the CTD 
and integrated in the pRB1017 plasmid  
AAACGAGACCATCCTCCTTCATTGC Reverse 
Oligonucleotide coding for the crRNA 
targeting the end of the CTD and 
integrated in the pRB1017 plasmid  
TCTTGTATGAATTTGGATCATAAGT Forward 
Oligonucleotide coding for the crRNA 
targeting the end of the CTD and 
integrated in the pRB1017 plasmid  
AAACACTTATGATCCAAATTCATAC Reverse 
Primer used to amplify the 5’ homo of 
the CTD and containing the restriction 
site for PvuII 
TTCATTAATGCAGCTGTCGGATTCACGGAGGCT Forward 
Primer used to amplify the 5’ homo of 
the CTD and containing the restriction 
site for EcoRI 
CCGGAATTCTGGATCCCCAGGCGAT Reverse 
Primer used to amplify the SEC in 
order to insert it in the plasmid with 
the CTD-S2S 
TGATCCTAACTCATAAGCGGCCGCGTAAGTTTA
AAATAAC 
Forward 
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Primer used to amplify the SEC in 
order to insert it in the plasmid with 
the CTD-S2S  
AAAAATCGGTACCCTGAAAATAACTTCG Reverse 
Primer used to amplify the SEC in 
order to insert it in the plasmid with 
the CTD-S2A 
GATCCGAACAGTTAAGCGGCCGCGTAAGTTTAA
AATAAC 
Forward 
Primer used to amplify the SEC in 
order to insert it in the plasmid with 
the CTD-S2A 
AAAAATCGGTACCCTGAAAATAACTTCG Reverse 
Primer used to amplify the 3’ homo of 
the CTD  
TTCAGGGTACCGATTTTTCCCGTTTTTTTGGGCA
ATTTTC 
Forward 
Primer used to amplify the 3’ homo of 
the CTD  
CAAGCTGTGACCGTCTACCGCCCACCCCTGATC
T 
Reverse 
Primer used to perform the Q5 site-
directed mutagenesis on the plasmid 
repair template for the mutated CTD 
ATGGTCTCCAGCATCGCCTG  Forward 
Primer used to perform the Q5 site-
directed mutagenesis on the plasmid 
repair template for the mutated CTD 
CCTCCTTCATTGAACGGCGA Reverse 
Primer 3191 used to screen the tagged 
SLD-3 strain  
ACTACAAGGACGACGACGACAAG Forward 
Primer 3192 used to screen the tagged 
SLD-3 strain  
CCTCCAACCACTCAAATTGTCCAC Forward 
Primer 3141 used to screen the tagged 
SLD-3 strain  
GGGTCGATGCGACGCAA Forward 
Primer 3194 used to screen the tagged 
SLD-3 strain  
GTATCATCAGAGAATGGCCTGTACC Reverse 
crRNA targeting the end of cdk-12 ACTGACTGATATTGTGATTG / 
Short primer to amplify the MAP tag  GTGAGCAAGGGCGAGGAGCT Forward 
Short primer to amplify the MAP tag  TTACTTGTACAGCTCGTCCA Reverse 
Long primer to amplify the MAP tag  CTGCCACCATCAGGAGGTCATGCACCTCCACCA
CCACCTCCACCAACACAGGCTTCTTCAACGTCG
CATAACAATCATCAACCAGTTCCTCAGTCTCAG
TACCAGTCAGTATTTTTCAAGGTGAGCAAGGGC
GAGGAGCT 
Forward 
  
50 
 
Long primer to amplify the MAP tag  TCAATTAAAAATTTAGACAGAAGAGCAGAAAA
AACCAAAAAAAAAAGGAATTTGTTGTCTATAAC
TAATAGAATAAAGAGAGTATACGTGTAAAAAT
AATCAACAAAAAAATCAGAATTTTTACTTGTAC
AGCTCGTCCA 
Reverse 
Primer used to screen for the 
expression of the MAP tag 
AAGCAGCTCCTACACAACCATC Forward 
Primer used to screen for the 
expression of the MAP tag 
GTCTTGTAGTTGCCGTCGTCC Reverse 1 
Primer used to screen for the 
expression of the MAP tag 
TTGTGGCGGATCTTGAAGTTGG Reverse 2 
Oligonucleotide coding for the first 
crRNA targeting the end of cdk-12 and 
integrated in the pRB1017 
TCTTGACTGACTGATATTGTGATTG Forward  
Oligonucleotide coding for the first 
crRNA targeting the end of cdk-12 and 
integrated in the pRB1017 
AAACCAATCACAATATCAGTCAGTC Reverse 
Oligonucleotide coding for the second 
crRNA targeting the end of cdk-12 and 
integrated in the pRB1017 
TCTTGTGATATTGTGATTGAGGAAC Forward 
Oligonucleotide coding for the second 
crRNA targeting the end of cdk-12 and 
integrated in the pRB1017 
AAACGTTCCTCAATCACAATATCAC Reverse 
Primer used to amplify the 5’ homo of 
cdk-12  
ACGTTGTAAAACGACGGCCAGTCGCCGGCAAG
ATGAATTGGAAGAAATAAAGATTTC 
Forward 
Primer used to amplify the 5’ homo of 
cdk-12  
CATCGATGCTCCTGAGGCTCCCGATGCTCCCTT
GAAAAATACAGATTGGTACTG 
Reverse 
Primer used to amplify the 3’ homo of 
cdk-12  
CGTGATTACAAGGATGACGATGACAAGAGATG
AAAATTCTGATTTTTTTGTTG 
Forward 
Primer used to amplify the 3’ homo of 
cdk-12  
GGAAACAGCTATGACCATGTTATCGATTTCTTC
CGGAAAATCAAAAAATC 
Reverse 
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